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1.1. The physiological roles of Reactive Oxidizing Species – ROS 
The presence of free radicals in biological materials was discovered less than 50 years ago 
(Commoner, Townsend et al. 1954). Immediately after, Denham Harman hypothesized that oxygen 
radicals may be formed as by-products of enzymatic reactions in vivo. In 1956, he described free 
radicals as a Pandora’s box, that may account for cellular damages, mutagenesis, cancer, and 
degenerative process of biological aging (Harman 1981). Present day evidence shows that reactive 
oxygen-, nitrogen- and chlorine-derived species, now collectively called “Reactive Oxidizing 
Species” (ROS), have a crucial role in human physiological and pathological processes (Vina, 
Borras et al. 2013). 
 
1.1.1 Reactive Oxygen Species 
From the univalent reduction of molecular oxygen, the superoxide radical anion (O2¯) is formed. 
This process is mediated in vivo by enzymes such as NAD(P)H oxidases, xanthine oxidase, by the 
electron leakage from mitochondrial respiratory complexes, or by redox reactive compounds. 
Superoxide dismutase (SOD) catalyzes the spontaneous dismutation of superoxide into hydrogen 
peroxide (H2O2) (Deby and Goutier 1990). In the presence of reduced transition metals (i.e., ferrous 
or cuprous ions), hydrogen peroxide can be converted into the highly reactive hydroxyl radical 
(OH) (Chance, Sies et al. 1979). More frequently, hydrogen peroxide is converted into water by 
the enzymes catalase or glutathione peroxidase. In the glutathione peroxidase reaction, glutathione 
(GSH) is oxidized to glutathione disulphide (GS-SG), which can be converted back to glutathione 
by glutathione reductase in an NADPH-consuming process. 
 
1.1.2 Reactive Nitrogen Species 
The nitric oxide radical (NO) is enzymatically produced by nitric oxide synthase (NOS) in higher 
organisms through the oxidation of one of the terminal guanido-nitrogen atoms of L-arginine. 
Depending on the microenvironment, NO can be converted into various other reactive nitrogen 
species, such as nitrosonium cation (NO+), nitroxyl anion (NO¯ ) or peroxynitrite (ONOO¯ ) 
(Stamler, Singel et al. 1992). Some of its physiological effects may be mediated through the 
intermediate formation of S-nitroso-cysteine or S-nitroso-glutathione (Gow and Stamler 1998). 
 
1.1.3 ROS in signal transduction and the revisited free radical theory of aging 
By the turn of the century, the free radical theory of aging appeared to be established. Much of the 
evidence gathered in favour of this theory was based on the correlation between high levels of 
antioxidant defences and increase in life-span. But other data have shown that in some cases, an 
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increased oxidative stress provoked longevity and metabolic health. In other words, evidence was 
produced either in favour or against the free radical theory of aging. The final knockdown for this 
theory came from epidemiological studies showing that antioxidant supplementation did not lower 
the incidence of many age-related diseases but, in some cases, increased the risk of death. 
Moreover, recent molecular evidence shows that, sometimes, an increased ROS formation, 
increases longevity. This is not surprising, since in the last decades it has become clear that cells 
generate ROS at lower levels to serve as signalling functions, that are crucial for cellular 
homeostasis. These oxidizing species function in signal transduction by reversible oxidative 
modifications of proteins, leading to phosphorylation cascades and altered gene transcription. ROS-
mediated signalling can promote cell proliferation and survival, but also can regulate programmed 
cell death, or necrosis, or, as recently demonstrated, autophagy, thereby playing a key role in the 
modulation of cell turnover (Fisher 2009). 
A fine balance between ROS generation and antioxidant levels allows the control of fundamental 
intracellular functions. If the cell can cope with the stress caused by relatively mild action of ROS, 
adaptation takes place and damages do not occur. If, however, ROS formation is dysregulated and 
surpasses antioxidant defences, oxidative stress is induced and subcellular damages and aging will 
take place (Fig. 1).  
 
 
Fig. 1. ROS and antioxidant defences in the mechanisms of cell survival or death. 
In physiological conditions, low ROS levels together with HAD (highly efficient and unaltered antioxidant 
defences) allow the generation of intracellular signals leading to cell homeostasis. In conditions of mild 
increase of ROS formation (mild oxidative stress), the HAD promote cell survival through the activation of 
cytoprotective and adaptive responses. When antioxidant defences are exhausted, LAD (low antioxidant 
defences), autophagy can be triggered. Under severe oxidative stress conditions, necrotic, apoptotic, or 
autophagic signalling pathways can be activated, which lead to cell death.  
From: Pietraforte D. and Malorni W, 2014 (Pietraforte and Malorni 2014). 
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The observation that ROS, which normally act as physiological signalling molecules, could activate 
intracellular pathways leading either to activation of survival mechanisms or to the triggering of the 
cell death program, earned them the epithet of “double edge sword” (Pietraforte and Malorni 2014). 
Thus, Viña and coworkers proposed “The cell signalling disruption theory of aging”, which 
postulates that aging is caused by a disruption of the whole signalling network involving ROS, and 
that, in general terms, it is better to increase endogenous defences by nutritional or physiological 
manipulations than administering antioxidant compounds or vitamins (D'Autreaux and Toledano 
2007). 
 
 
 
Fig. 2. The double edge sword of free radicals and longevity. 
When radicals cause severe effects on biomolecules, it causes damage (irreversible alterations) and shortens 
life-span, whereas when the aggression is mild, endogenous antioxidant defences are produced, which 
extends the organism longevity. 
From: Vina J, 2013 (Vina, Borras et al. 2013). 
 
1.1.4 The NADPH oxidases: Nox family  
Mitochondria were considered for a long time the main source of intracellular ROS as a part of 
aerobic respiration, but the demonstration that ROS are produced in response to growth factors, 
cytokines, or G protein-coupled receptor agonists, raised the hypothesis of the existence of other 
intracellular ROS sources, where oxidant production occurs nearby to the intended target. In fact, 
ROS production in the precise subcellular compartment after receptor activation is essential for 
specific redox signalling. Therefore, in order to act as efficient second messengers, ROS must 
satisfy the stringent criteria required for the signal transduction modulation, that is, the oxidation 
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should be a) mild, fast and reversible, b) regulated and compartmentalized, c) specific for target 
proteins and d) able to induce a distinct cellular biochemical outcome (Pietraforte and Malorni 
2014).  
The discovery of NADPH oxidases isoforms widely distributed among many non-phagocytic cell 
types, has brought to the notion that these membrane-bound enzymes appeared to be the major 
source of intracellular ROS (Ushio-Fukai and Urao 2009). 
These regulated enzyme, now recognized to have specific subcellular localization, are the best 
candidate for localized and programmed ROS production, which activates specific redox signalling 
pathways mediating various cell functions. Moreover, the NADPH oxidase subunits strictly interact 
with targeting proteins. 
These enzyme complexes contain a homologous catalytic subunit, Nox, for this reason they form 
the Nox family, which differs primarily in the flavocytochrome component. Five Nox proteins have 
been described, along with two additional enzymes called DUOX, which contain a peroxidase-like 
domain (Altenhofer, Radermacher et al.).  
 
Fig. 3. Current model of the active Nox complexes. 
Each of the seven members of Nox family requires a different set of conditions and protein associations. The 
cytosolic subunits that are believed to assemble onto each Nox isoform in the active oxidase state are shown. 
From: I. A. Ghouleh et al., (Al Ghouleh and Magder 2011). 
 
All the seven Nox members contain two iron-heme prosthetic groups, as well as a flavin adenine 
dinucleotide (FAD) and an NAPDH-binding domain in the cytosolic c-terminus. FAD is 
constitutively bound to the enzyme, whereas NADPH serves as its substrate. Nox2 is the membrane 
oxidase isoform identical to the phagocytic NADPH oxidase complex, nevertheless the rate of 
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superoxide generation by Nox2 in non-phagocytic cells is lower than the levels required for 
microbicidal function, but is sufficient for cell signalling (Fisher 2009). Nox enzymes catalyze the 
electron transport across plasma membrane from NADPH to molecular oxygen outside the cell, 
generating the superoxide anion in the extracellular space. Here, the neo-formed superoxide anion 
undergoes to spontaneous or catalysed dismutation reaction, giving rise to hydrogen peroxide, 
H2O2.  
 
 
 
Fig. 4. Schematic representation of common Nox features. 
Shown here are the key features in common for all Nox family members, along with the heme-binding site 
(Fe) and the FAD- and NADPH-binding domains.  
From: I. A. Ghouleh et al.,(Al Ghouleh and Magder 2011). 
 
It is generally believed that, once generated, H2O2 could simply diffuse into the cell across the 
plasma membrane for signalling purposes, but recent evidence demonstrates that hydrogen peroxide 
might preferentially enter the cell through specific plasma membrane aquaporin channels (Bienert 
and Chaumont 2014).  
The hypothesis that H2O2 represents the signal molecule is compatible with the properties of this 
peroxide, that coincide with the theoretic requirements for a second messenger function: it is 
produced by a regulated enzyme in a specific site and its concentration is regulated through rapid 
removal by various enzymes with specificity for it (Fisher 2009).  
Depending on the cell type and on the different subcellular localization, Nox enzymes activate 
specific, context-dependent signalling pathways via localized production of ROS following 
numerous stimuli, including growth factors, cytokines and physical or mechanical stresses. On this 
regard, it has been recently demonstrated that specialized plasma membrane microdomains called 
caveolae/lipid rafts, rich in cholesterol and sphingolipids, concentrate multiple signalling molecules, 
thus forming signalling platforms (Ushio-Fukai 2009). The assembly of functional active NADPH 
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oxidase and subsequent ROS production has been demonstrated to be dependent on caveolae/lipid 
rafts in many cell types, such as, for example, in vascular and endothelial cells (Hilenski, Clempus 
et al. 2004). As far as the Nox stimulation is concerned, it has been reported that Nox1 expressed in 
vascular cells and Nox2 in endothelial cells are activated by AngII, thrombin, prostaglandin F, 
PDGF and VEGF, whereas in the same cells Nox4 is regulated by shear stress, mitochondrial 
dysfunction, hypoxia and transforming growth factors (Hilenski, Clempus et al. 2004).  
Thus, recognition of the cellular context is essential to an appreciation of Nox-mediated signal 
transduction; the cell type, the functional endpoint, the complement of Nox proteins expressed in 
the cell, and the tissue environment must be considered. 
 
1.1.5 The Aquaporin family 
Aquaporins (AQPs) are integral, transmembrane, small hydrophobic water channel proteins 
extensively expressed in many organs and tissues, where they play a prominent role in regulating 
physiological functions, particularly those involved in fluid transport.  
The first characterization of AQP, now named as AQP1, was performed in 1992 by Peter Agre, who 
demonstrated that the presence of a transmembrane channel protein could explain the high 
membrane water permeability of erythrocytes and other cells, which could not be justified only by 
simple passive diffusion of water molecules across the lipid bilayers (Agre 2004). Currently, it is 
known that AQP expression on cell plasma membrane increases osmotic membrane water 
permeability up to about 50-fold compared to the lipid bilayer (Verkman 2012). 
From a structural point of view, AQPs usually possess a tetrameric organization in membranes. 
Each monomer is quite small, about 30 kDa, and comprises six transmembrane α-helical segments, 
two half helices and five connecting loops of variable length, with the N- and C-terminal domains 
sited in the cytoplasm. The mechanism allowing AQPs to facilitate water (or glycerol) transport 
involves an aqueous pore; however, the conveyance of protons is avoided, thus hindering the 
dissipation of proton gradients (Verkman 2012). 
To date, the family consists of 13 members, highly conserved across the plant and animal kingdoms 
and it could be divided in two groups, the mainly water-permeable aquaporins and the mainly 
glycerol-permeable aquaglyceroporins. 
The major AQP function is to facilitate the transport of water or glycerol over cell plasma 
membranes; some members of AQP family are also able to transport other small molecules, such as 
urea, CO2, ammonia, nitric oxide. 
In the last decade, it has been demonstrated that also H2O2 can be carried by some AQP members in 
several living organisms (Bienert, Moller et al. 2007). 
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Only specific AQP isoforms are able to facilitate the passive diffusion of H2O2 across biological 
membranes, thereby having a crucially impact on the membrane permeability of H2O2. These AQP 
isoforms are AQP1, AQP3 and AQP8 and they were named “peroxoporins” by Henzler and Steudle 
(Henzler and Steudle 2000). 
Their transport ability was ascertained through experiments in which AQP inhibitors, such as 
mercuric chlorid, silver nitrate, or phloretin, were found to significantly inhibit the transmembrane 
flux of H2O2. 
This regulated entry of H2O2 provides another potential mechanism through which oxidants could 
be channelled to an intended target and thereby achieve some measure of overall signalling 
specificity (Finkel 2011). 
 
1.1.6 Downstream targets of H2O2 signalling 
Transmission of a redox signal initiated by H2O2 to a protein occurs through the oxidative 
modification of some amino acid side chains, such as, in decreasing order of reactivity and 
biological reversibility, cysteine, methionine, proline, histidine and tryptophan. In particular, thiol 
modification is a key factor in H2O2 sensing and perception in proteins (Sies 2014). 
Growth factors, through H2O2 production, induce downstream effects on tyrosine phosphorylation 
acting by different mechanisms, such as the inactivation of protein phosphatases, thereby increasing 
the level of protein phosphorylation. Alternatively, direct modification of the growth factor receptor 
by H2O2 at a critical active site cysteine was shown to enhance tyrosine kinase activity. 
Insulin signalling was probably the first transduction chain in which H2O2 was invoked as a second 
messenger, thus this peroxide was called an “insulin-mimetic” (Heffetz, Bushkin et al. 1990). 
It is well known that insulin signals through the PI3K/Akt signalling pathway, and it has been 
shown that activation of this pathway supports survival of cells exposed to hydrogen peroxide, in 
agreement with the insulin-mimetic function of H2O2. The major functions of the PI3K/Akt 
signalling pathway are to block apoptotic processes and to regulate fuel metabolism. Hence, the 
activation of this pathway by ROS leads to interference with cellular proliferation, survival and 
energy metabolism. 
Regarding non-receptor kinases, signal-mediated H2O2 production increases Akt activation and 
many studies documented the H2O2-induced activation of MAPK pathway. 
In Fig. 5 it is reported a possible mechanism of a growth factor signal transduction: after the ligand-
receptor binding, the PI3K/rac pathway is activated, leading to the Nox activation and the 
consequent superoxide production outside the cell. In parallel, a src family member switches to the 
active form thanks to a phosphorylation reaction occurring near the receptor tyrosine kinase 
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domain. In the active form, the src kinase is able to inactivate the main intracellular peroxide 
scavenger, peroxiredoxin (Prx-1), thus allowing for the local accumulation of hydrogen peroxide. 
When H2O2 reaches sufficient levels, target molecules such as protein phosphatases can be 
reversibly oxidized on their cysteine residues, increasing the level of protein phosphorylation. 
The oxidation of critical thiols are centrally involved also in the activation of essential switches in 
defense reactions, such as the Nrf2/Keap1 system, important in chemopreventive and cytoprotective 
functions (Sies 2014). 
 
 
 
Fig. 5. Growth factor signalling through H2O2 as second messenger. 
The signalling pathway resulting after growth factor (GF) stimulation is shown. Ligand binding to its receptor 
stimulates, through a PI3K/Rac-dependent process, superoxide production from an isoform of the Nox family. 
Extracellularly produced H2O2 is channeled back into the cell through specific plasma membrane aquaporins. Although 
hydrogen peroxide (red circles) can be rapidly and efficiently degraded by intracellular antioxidants, Src family 
members stimulated by growth factors appear to phosphorylate and subsequently inactivate the main intracellular 
peroxide scavenger, peroxiredoxin (Prx I). This Prx1 inactivation only occurs in the region surrounding the stimulated 
growth factor, thus allowing for the local accumulation of hydrogen peroxide. When the ROS reach sufficient levels, 
target molecules such as protein phosphatases (PTP) can be reversibly oxidized. 
From: T. Finkel, (Finkel 2011). 
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1.2 ROS in diseases 
Given the essential role played by redox physiological signalling, it is not surprising that alteration 
or dysfunction of this system contribute to the development of many disease processes. Therefore, 
ROS are involved in a wide range of pathologies. Nonetheless, the precise role played by ROS 
remains controversial, since it is not clear whether a rise in ROS causes or merely correlates with 
the disease states.  
 
 
 
Fig. 6. ROS involvement in many diseases.  
From: Brieger et al., (Brieger, Schiavone et al. 2012). 
 
1.2.1 Cancer 
High levels of ROS have been detected in several cancers, such as in breast, ovarian, liver, colon, or 
tumour epithelial cells (Pereira, Chaves et al. 2013).  
In cancer cells, the constitutive and uncontrolled activation of growth factor pathways leading to 
cellular growth, survival and proliferation, changes the course of normal cell machinery. This 
allows cancer cells to take up abundant nutrients, survive stress and continuously proliferate. This 
unusually high metabolism rate causes abundant ROS generation from mitochondria, endoplasmic 
reticulum and, above all, from NADPH oxidases (Cairns, Harris et al. 2011). In fact, cancer cells 
generate higher ROS levels than their non-transformed counterparts. For example, leukaemia cells 
freshly isolated from blood samples of patients with chronic lymphocytic leukaemia, showed 
increased ROS production compared with normal lymphocytes (Zhou, Hileman et al. 2003). At an 
advanced stage, cancer cells exhibit genomic instability and show an even more higher increase in 
12 
 
ROS generation, due in part to a “vicious cycle”, in which ROS induce gene mutations, leading to 
further metabolic malfunctions and ROS generation (Trachootham, Alexandre et al. 2009). 
As above stated, a part of the high ROS content in tumour cells arises from mitochondrial 
dysfunction coupled with the metabolic readjustment to generate ATP. The highly proliferative rate 
exhibited by tumour cells requires high levels of energy and building blocks for biomass 
production. Despite this high energy requirement, cancer cells shift their oxidative metabolism to 
glycolysis, a process known as the “Warburg effect”, which is observed regardless the oxygenation 
levels (Warburg 1956). The mitochondrial dysfunction probably causes both the shift of the 
oxidative metabolism toward glycolysis and the leakage of electrons giving rise to oxygen radical 
species owing to the compromised efficiency of the electron transport chain. Malignant, rapidly 
growing tumor cells, typically have glycolytic rates up to 200 times higher than those of their 
normal tissues of origin and this occurs even if oxygen is plentiful. This metabolic strategy is also 
useful in conditions of reduced oxygen tension (hypoxia), which often occurs during tumour 
initiation and development. Under hypoxic conditions, cells undergo a shift from aerobic to 
anaerobic metabolism and cells activate signalling pathways which regulate proliferation, 
angiogenesis and death. The adaptation of tumour cells to hypoxia contributes to the malignant 
phenotype and to aggressive tumour progression (Arnold, Shi et al. 2001). 
Another part of the high ROS content in tumor cells originates from the Nox proteins, whose 
expression has been reported to increase in many cancer cell types; furthermore, activated NADPH 
oxidase seems to be required for the control of proliferation and the maintenance of the transformed 
state (Meitzler, Antony et al. 2014). 
In particular, Nox isoforms have been described to be altered in leukaemia cells, and such changes 
have been specifically linked to sustained leukaemia cell viability, proliferation and migration, as 
well as altered drug susceptibility. It has been also shown that leukemic oncogenes (such as 
BCR/ABL, Flt3-ITD or c-Kit) are able to control Nox activation and assembly via the PI3K/Akt 
and MAPK pathways (Irwin, Rivera-Del Valle et al. 2013). 
As above mentioned, both solid and liquid tumours are often under hypoxic conditions, thereby 
cells activate signalling pathways in order to adapt themselves to this environment, possibly leading 
to the angiogenic process. Indeed, ROS production within tumor cells dramatically promotes the 
release of paracrine growth factors such as VEGF and the expression of its receptors, VEGF 
receptor-1 and -2, which, in turn, stimulate proliferation, migration, and tube formation in nearby 
endothelial cells (Maraldi 2013). 
NADPH oxidase within endothelial cells cooperates with growth factors, such as VEGF released by 
tumours, to stimulate endothelial cell proliferation and then angiogenesis. Thus, Nox isoforms as 
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ROS source in tumours and in endothelium may be considered novel targets for antiangiogenic 
treatment.  
If increased ROS levels are essential to promote and reinforce proliferative signals, it conceivable to 
suggest that antioxidants could serve as tumour suppressors, reducing cellular ROS to levels that do 
not support proliferation. On the contrary, cancer cells that survive intrinsic oxidative stress may 
have mobilized a set of adaptive mechanisms, which consists in activating ROS–scavenging 
systems to cope with the stress and in the inhibition of apoptosis. Indeed, besides the generation of 
ROS, the same Nox activity is able to elevate the expression of the antioxidant heme oxygenase-1 
(HO-1), thereby altering the balance of oxidative stress in the cells. There is also evidence of 
enhanced activation of the antioxidant program driven by the nuclear factor erythroid 2-related 
factor 2 (Nrf2) transcription factor, which has differential impacts on tumorigenesis (DeNicola, 
Karreth et al. 2011; Mateescu, Batista et al. 2011; Sporn and Liby 2012). 
Therefore, at the same time of ROS production, cancer cells maintain a high level of antioxidant 
activity to prevent the ROS-induced cell death. This opens two ways to approach ROS therapy in 
cancer: should treatments focus on lowering ROS levels to prevent signalling or on increasing ROS 
to selectively kill cancer cells? A systematic review of randomized control studies with many 
antioxidants, i.e. β-carotene, vitamins A, E, and C concluded no significant benefits, on the contrary 
detrimental effects in both cancer prevention and therapy (Bjelakovic, Nikolova et al. 2007). 
 
 
 
Fig. 7. Leukemic oncogenes control NOX assembly and activity in leukaemia cells. 
Leukemic oncogenes, including BCR/ABL, Flt3-ITD, and c-Kit, increase ROS levels, leading to translocation of 
nuclear factor erythroid 2-related factor 2 (Nrf2) to the nucleus, where it elevates mRNA expression of the NOX 
components p67phox, p47phox, and p40phox. Then they can interact to form the active NOX complex. 
From: M.E. Irwin et al., (Irwin, Rivera-Del Valle et al. 2013). 
 
14 
 
1.2.2 Cardiovascular diseases 
ROS at physiological levels are now appreciated to function as signalling molecules to regulate a 
wide range of processes in the cardiovascular system and to contribute to the maintenance of 
cardiovascular homeostasis (Droge 2002). In contrast, excessive and/or sustained increase in ROS 
generation plays a pivotal role in the initiation, progression and clinical consequences of 
cardiovascular disorders (CVD) (Sugiyama, Kugiyama et al. 2004; Touyz and Briones 2011; 
Csanyi, Yao et al. 2012). Although mechanisms need to be elucidated, it is clear that Nox enzymes 
have a crucial function. Numerous studies have examined the expression levels of Nox isoforms in 
the vascular wall in experimental models of hypertension, focusing in particular on the increase of 
Nox1, Nox2, Nox4 and, more recently, Nox5 (Guzik, Chen et al. 2008). 
Most CDVs are a direct consequence of atherosclerosis. Free radicals and ROS, derived primarily 
from Nox and mitochondria, lead to the oxidation of low density lipoproteins, that strongly 
contribute to the atherosclerotic plaque formation and progression. Plaques and platelets are also 
involved in the onset of vascular inflammatory processes, through macrophage activation leading to 
the release of pro-inflammatory cytokines, such as tumor necrosis factor-α, interleukin-1, 
interferon-γ, AngII, and endothelin-1 (Massberg, Schurzinger et al. 2005). 
An important risk factor for atherosclerosis and heart failure is hypertension, whose 
pathophysiology is strictly linked to both Nox-derived ROS via renin-angiotensin-aldosterone 
system (Feng, Yang et al. 2012) and mitochondrial ROS (Dikalova, Bikineyeva et al. 2010). 
Moreover, Nox system and mitochondria create a cross-talk that elicits a vicious cycle of “ROS 
catalyzed ROS production” (Chen and Keaney 2012). 
It has been shown that H2O2 plasma production is higher in hypertensive patients than normotensive 
subjects. Moreover, patients with hypertension have decreased content of antioxidant enzymes 
(SOD, glutathione peroxidase, and catalase) and reduced levels of antioxidant vitamins A, C, and E 
(biblio). In addition, shear stress, vascular endothelial alterations and elevated blood pressure 
generate a loop of dysfunction that reduces vasodilation and increases contraction. Although there is 
still no firm evidence that oxidative stress causes hypertension in humans, a relationship between 
oxidative stress and hypertension has been demonstrated, so that circulating biomarkers of ROS act 
as oxidative stress markers able to predict cardiovascular diseases (Montezano and Touyz 2012). 
Pathology like diabetes increases the level of advanced glycation end products (AGEs), that play a 
pivotal role in the development and progression of diabetic heart failure. Patients with diabetes have 
an increased incidence of atherosclerotic cardiovascular, peripheral arterial, and cerebrovascular 
disease. Hypertension and abnormalities of lipoprotein metabolism are often found in people with 
diabetes. 
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A key to contrast the incidence of CVD could be represented by bioactive compounds found in 
natural food. Plant-derived nutraceutical compounds were largely investigated in vivo and in vitro in 
the prevention and/or treatment of CVD (Siow and Mann 2010). In particular, isoflavones 
(genistein, daidzein, and equol) increase eNOS and antioxidant gene expression in the vasculature 
(Mahn, Borras et al. 2005) and stimulate eNOS activity at basal cytosolic Ca2+ levels via ERK1/2 
and PI3-kinase/Akt-dependent pathways (Siow, Li et al. 2007), resulting in reduced oxidative stress 
and increased NO bioavailability. The molecular mechanisms by which soy isoflavones and other 
natural compounds as sulforaphane counteract oxidative stress in CVD remain to be better 
investigated and nutraceutics could represent a prevention strategy against CVD. 
 
1.2.3 Diabetes 
Diabetes mellitus is a family of metabolic diseases characterized by hyperglycemia deriving from 
defects in insulin secretion, insulin action or both, and leading to long-term damage, dysfunction, 
and failure of various organs, primarily kidneys, eyes, nerves, heart, and blood vessels. 
Type 1 diabetes originates from an autoimmune destruction of pancreatic β-cells causing an 
absolute deficiency of insulin secretion, completely insufficient to prevent hyperglycemia. 
Type 2 diabetes mellitus is an endocrine disorder characterized by insulin resistance and relatively 
deficient production of insulin, provoking hyperlipidemia, elevating free fatty acids, increasing 
advanced glycation end-products and overproducing mitochondrial superoxide anion. Under 
physiological conditions, the activation of the insulin receptor by insulin stimulates signal 
transduction pathways: insulin receptor substrate (IRS1/2) induce the phosphorylation of 
phosphoinositide 3 kinase (PI3K), the conversion of PIP2 to PIP3 and the activation of pleckstrin 
homology (PH) domains to the cell surface. PH activates threonine protein kinases protein kinase B 
(PKB or Akt), which constitutively induce Glut4, and in a lesser extent, Glut1 translocation from 
their intracellular pool to the plasma membrane, and glucose transport into the cell (Leney and 
Tavare 2009). In particular, organs like skeletal muscle, liver, and adipose tissue enhance their 
uptake of glucose after the insulin stimulation (Pirola, Johnston et al. 2004). In addition to this 
recruitment, there is also evidence that insulin modifies the intrinsic activity of both Glut4 and 
Glut1 (Whitesell and Abumrad 1985). Glut1 is a facilitative glucose transporter which is expressed 
ubiquitously in human tissues and it is correlated to the promotion of cancer development and 
cancer’s metabolism (Baer, George et al. 2002). 
It has been shown that ROS are produced in various tissues under diabetic conditions (Baynes and 
Thorpe 1999). The aforementioned production of superoxide anion activates different pathways, for 
instance an increase of AGE formation, an activation of protein kinase C isoforms, a rise in the 
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activity of hexosamine pathway, or a growth of polyol pathway flux. Moreover, AGEs and insulin 
activate Nox enzymes, leading to further ROS production. The major risk factor for the progression 
of diabetic complications is oxidative stress; indeed, ROS induced under diabetic conditions are 
involved in the progression of pancreatic β-cell dysfunction and insulin resistance found in type 2 
diabetes (Rains and Jain 2011). Oxidative stress plays a pivotal role in the development of diabetes 
because the permanent high glucose induces increase of mitochondrial ROS, causing microvascular 
and cardiovascular complications (Giacco and Brownlee 2010). Type 2 diabetes is also associated 
with obesity since adipose tissue produces a number of hormone-like compounds that can increase 
insulin resistance (Jackson and Ahima 2006). 
There are different strategies to counteract the effects of diabetes, for example synthetic drugs 
(Rochette, Zeller et al. 2014) and natural compounds as resveratrol (Szkudelski and Szkudelska 
2014) or steviol glycosides from Stevia Rebaudiana (Rizzo, Zambonin et al. 2013). 
 
1.2.4 Neurological diseases 
The brain is particularly vulnerable to oxidative stress because it is rich in polyunsaturated fatty 
acids, it consumes much more oxygen compared to other tissue, it has less antioxidant enzymes 
than other organs, and it has higher level of iron in certain regions. Oxidative stress may induce 
neuronal damage, modulate intracellular signalling, and may ultimately lead to neuronal death by 
apoptosis or necrosis, induce early event of Alzheimer and Parkinson diseases, increase 
inflammatory disorders. In the brain, even small redox imbalances can be deleterious (Hsieh and 
Yang 2013). 
Moreover, the brain is exposed throughout life to excitatory amino acids (such as glutamate), whose 
metabolism produces ROS, thereby promoting citotoxicity. 
Alzheimer implicates a loss of neurons, loss of memory, dementia and finally death (Selkoe 2004). 
ROS favourite lipid peroxidation, the deposition of amyloid and generate a protein cross-linking 
that aggregates the tau protein (Troncoso, Costello et al. 1993). 
Parkinson is a disorder of motor system that starts with tremor up to decline of several motor 
centration functions (Sonntag, Carter et al. 2005). ROS are produced during the normal metabolism 
of dopamine, and they increase the level of polymerized oxidation products of dopamine, the toxic 
neuromelanin. Substantia nigra of Parkinson patients shows an impaired redox balance between 
GSH and GSSG: this could be a critical primary event, leading to a weakening or deficiency of the 
natural antioxidant cellular defence mechanisms thereby triggering degeneration of the nigral 
neurons. 
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Oxidative stress has been linked to other neurodegenerative diseases, such as cognitive impairment 
and dementia in the elderly, amyotrophic lateral sclerosis, schizophrenia and neuroleptic induced 
tardive dyskinesia, and perhaps Huntington's disease (Gilgun-Sherki, Melamed et al. 2001). 
 
1.2.5 Aging 
Aging is a physiological process, dynamic and irreversible, which occurs in the natural 
development of living organisms over time (Dziechciaz and Filip 2014). 
In particular, aging is a progressive decline in the efficiency of biochemical and physiological 
processes (Rahman 2007). The aging’s degeneration gives rise to several pathologies, such as 
sarcopenia, atherosclerosis and heart failure, osteoporosis, macular degeneration, pulmonary 
insufficiency, neurodegenerative diseases (such as Alzheimer’s and Parkinson’s diseases), cancer 
and many others. Many different mechanisms relate aging to oxidative stress, but since the free 
radical theory of aging appeared to be established, the link between ROS and aging is highly 
debated. Recent theories assert that mitochondrial respiration plays a major role in preserving 
longevity and it has been demonstrated that impaired mitochondrial functioning occurs with aging 
and leads to deterioration in the structure and function of tissues, implicating this process in the 
development of several age-related diseases (Martin-Montalvo and de Cabo 2013). The proposed 
causes of mitochondrial dysfunction involve the synthesis of nonfunctional complexes of the 
electron transport chain, damaged mitochondrial DNA and/or the accumulation of nonfunctional 
proteins by ROS-induced modifications.  
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1.3 Redox Homeostasis 
1.3.1 Maintenance of redox homeostasis 
ROS possess a multitude of biological functions, including host defence (direct and indirect killing 
of microorganisms), biosynthetic processes (for example, crosslinking of matrix proteins and 
iodination of thyroid hormones), and cell signalling. 
The term redox signalling is widely used to describe a regulatory process in which the signal is 
delivered through redox chemistry. Redox signalling is used by a large range of organisms, 
including bacteria, to induce protective responses against oxidative damage and to reset the original 
state of “redox homeostasis” after temporary exposure to level of ROS higher than physiological 
one (Droge 2002). 
The concentrations of free radicals and reactive nonradical species are determined by the balance 
between their rates of production and their rates of clearance by various antioxidant compounds and 
enzymes (Halliwell 1989). Antioxidants include the enzymes SOD, glutathione peroxidase (GPx), 
and catalase, as well as nonenzymic compounds such as α-tocopherol (vitamin E), β-carotene, 
ascorbate (vitamin C), Coenzyme Q, and glutathione. 
 
1.3.2 What happens if oxidant-antioxidant balance is changed? 
Living cells and tissues have several mechanisms for re-establishing the original redox state after a 
temporary exposure to increased ROS concentrations. Elevated ROS concentrations induce in many 
cells the expression of genes whose products exhibit antioxidant activity (Droge 2002). A major 
mechanism of redox homeostasis is based on the ROS-mediated induction of redox sensitive signal 
cascades which lead to increased expression of antioxidant enzymes or an increase in the cysteine 
transport system. Moreover, proteolysis contributes to the maintenance of redox homeostasis, since 
proteins provide less ROS scavenging activity than an equivalent amount of free amino acids. Cells 
or tissues are in a stable state if the rates of ROS production and scavenging capacity are essentially 
constant and in balance. Redox signalling requires that this balance is disturbed by an increase in 
ROS concentrations or a decrease in the activity of one or more antioxidant systems. 
If the initial increase in ROS is relatively small, the antioxidant response may be sufficient to 
compensate for the increase in ROS and to reset the original balance between ROS production and 
ROS scavenging capacity. Pathological conditions may develop in more extreme cases of 
persistently high ROS levels (Arnold, Shi et al. 2001). 
Natural human antioxidant defences are not always sufficient to maintain the proper ROS balance. 
Therefore, a normal process may become pathological if this failure persists for a long time. 
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Many epidemiological studies support the relationship between oxidative state and global health as 
the high consumption of foods rich in antioxidants is associated with lower disease rates or 
preventive protection (Wannamethee, Lowe et al. 2006). 
 
1.3.3 Hormesis 
Hormesis is a dose response phenomenon characterized by a low dose stimulation and a high dose 
inhibition. In other words, hormesis is an adaptive response to a negative stimulus. After 
stimulation by a negative stimulus, the cell/organism is more resistant to the future stimuli, that 
could act in a higher form: a toxin/stressor renders cells/organisms resistant to higher (and normally 
harmful) doses of the same stressing agent (Martins 2011). 
There are several evidences that, after exposition of low concentration of hydrogen peroxide, cells 
activate numerous biochemical mechanisms that strengthen the antioxidant cell defences. 
Superoxide anions and hydrogen peroxide are regulated by SOD that catalyzes the dismutation of 
superoxide anion to H2O2 and oxygen. H2O2 enhances SOD activity that decreases superoxide 
levels, thus creating a feedback regulatory mechanism that promotes hormesis effects by 
maintaining hydrogen peroxide at homoeostatic levels (Ludovico and Burhans 2014). 
In human skin keratinocytes, low concentrations of hydrogen peroxide increase the replicative 
lifespan, together with telomere length (Yokoo, Furumoto et al. 2004). 
Since in mammalian cells telomere elongation is inhibited by superoxide anions (Passos, Saretzki et 
al. 2007) and SOD activity enhances telomere maintenance (Serra, von Zglinicki et al. 2003), the 
extension in replicative lifespan could possibly be related to H2O2-induced SOD activity. 
Different natural compounds with a particular chemical reactivity are able to activate adaptive 
cellular stress response pathways. For example, kinases and transcription factors induce the 
expression of genes encoding antioxidant enzymes, such as phase 2 enzymes, neurotrophic factors 
and other cytoprotective proteins (Calabrese, Cornelius et al. 2012). This adaptive response is very 
close to hormesis phenomena. 
 
1.3.4 The Nrf2/Keap1/ARE pathway 
The induction of many cytoprotective enzymes in response to reactive chemical stress is regulated 
primarily at the transcriptional level. This transcriptional response is mediated by elements termed 
Antioxidant Responses Elements, ARE, initially found in the promoters of genes encoding the two 
major detoxication enzymes, glutathione S-transferase A2 and NADPH:quinone oxidoreductase 1. 
Now, it has been demonstrated that ARE increase the synthesis of many ARE-dependent 
antioxidant enzymes in different cell systems, such as glutathione reductase, glutathione peroxidase, 
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glutaredoxin, thioredoxin reductase, heme oxygenase 1 (HO-1) and peroxiredoxin 1 (Prx-1). The 
ARE possesses structural and biological features that characterize its unique responsiveness to 
oxidative stress. Compounds that have the propensity to react with sulfhydryl groups such as diethyl 
maleate, isothiocyanates, and dithiothiones are also potent inducers of ARE activity. Thus, 
alteration of the cellular redox status due to elevated levels of ROS and electrophilic species and/or 
a reduced antioxidant capacity appears to be an important signal for triggering the transcriptional 
response mediated by this enhancer.  
Activation of gene transcription through the ARE is mediated primarily by Nrf2. The Nrf2/Keap1 
pathway is the most important regulator of cytoprotective responses to endogenous and exogenous 
stresses caused by reactive ROS and electrophiles (Kansanen, Jyrkkanen et al. 2012). 
Nrf2/Keap1/ARE system is mediated by some natural compounds (e.g. SF and resveratrol) but also 
by a change of electrophilic balance. Under basal conditions Keap1, a cytosolic protein rich in 
cysteine residues, binds Nrf2, thereby keeping this factor in the negative form. When the 
electrophilic balance is changed or due to the presence of compounds like SF, cysteine residues are 
oxidized and Nrf2 is released (Baird and Dinkova-Kostova 2011), turning on its active state. Then, 
Nrf2 can translocate into the nucleus, where it binds ARE in the regulatory regions of target genes 
(Baird and Dinkova-Kostova 2011). 
Among the genes induced in response to oxidative stress, whose expression is regulated by the 
binding of Nrf2, the heme oxygenase HO-1 is of particular interest, since the protein product of this 
gene has antioxidant, anti-inflammatory and anti-apoptotic activity. 
HO are rate-limiting enzymes in heme catabolism. Heme oxygenases catalyze the reduction of 
heme to biliverdin, carbon monoxide and ferrous ions in the presence of NADPH and oxygen, and 
the produced biliverdin is further reduced to bilirubin in the presence of biliverdin reductase 
(Takahashi, Takahashi et al. 1998). Both biliverdin and bilirubin are efficient ROS scavengers 
(Babusikova, Jesenak et al. 2008). 
HO-1 plays several role in oxidative balance, in particular related to vasculature and diabetes (Siow, 
Sato et al. 1999); indeed HO-1 knockout mice exhibit an high susceptibility to hypertension 
(Wiesel, Patel et al. 2001).  
In addition, HO-1 is a potential target for cancer therapy, because this enzyme gives survival and 
growth advantages to malignant cells by means of its anti-apoptotic activity. The modulation of 
HO-1 expression affects cellular growth or survival of myeloid leukaemia cells (Miyazaki, Kirino et 
al. 2010). 
Another Nrf2-induced enzyme is represented by Prx-1. Peroxiredoxins are a class of thiol 
peroxidases that degrade hydroperoxides to water. Peroxiredoxin enzymes contain a conserved 
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cysteine residue in the N-terminal region that is the primary site of oxidation by H2O2. This family 
protects cellular components by removing the low levels of hydroperoxides and peroxinitrites 
produced as a result of normal cellular metabolism in the cytosol (Rhee, Chae et al. 2005). Several 
features of the Prxs make measurement of their redox state a valuable biomarker of oxidative stress, 
moreover the varied intracellular expression pattern of different Prxs enables exploration of redox 
disruption in different cellular compartments. 
Nrf2 activates another fundamental pathway involved in the maintenance of the intracellular 
antioxidant defence enzymes in response to stress, the GSH system. Nrf2-deficient mice are more 
susceptible to liver damage due to diminished basal GSH levels and an impaired compensatory 
induction GSH synthesis (Lu 2009). Moreover, decreased level of GSH were observed in long-term 
exposure to high glucose in mouse endothelial cells that became more vulnerable to oxidative stress 
(Kline, Bassit et al. 2009). 
 
1.3.5 Klotho 
Klotho is a newly discovered anti-aging gene, found in 1997 by Kuro-o and his research group. The 
name is derived by one of three Fates of Greek mythology who regulates the life and the destiny of 
humanity. 
Klotho protein exists in two forms, a transmembrane and a soluble secreted form. 
The membrane protein (130 kDa) is mainly expressed in the kidney, parathyroid glands and choroid 
plexus of the brain; the extracellular domain of Klotho transmembrane form can be enzymatically 
cleaved off and released into the systemic circulation, where it acts as β-glucuronidase and as a 
hormone. The Klotho transmembrane family are formed by α-, β-, and γ-Klotho. 
The second transcript is soluble Klotho, smaller than the membrane form, it may be found in the 
blood, cerebrospinal fluid, and in mammal urine. Klotho deficiency results in early appearance of 
multiple age-related disorders and premature death, whereas overexpression of Klotho exerts the 
opposite effect (Kuro-o 2010). 
Studies have shown that the membrane and the secreted form have distinct functions, all related to 
regulatory effects on general metabolism. 
Klotho regulates the level of Ca2+ in the blood: Klotho -/- mice show an increase of this cation in 
the blood and the urinary excretion. Moreover, absence of Klotho increases the vitamin D serum 
level. All these events induce the demineralisation of the bones (Chang, Hoefs et al. 2005). 
Klotho also inhibits sodium-dependent phosphate co-transporters that mediate phosphate uptake 
(Hu, Kuro-o et al. 2010). In vascular smooth muscle cells, this inhibition prevents vascular 
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calcification events, since excessive phosphate influx in these cells promotes a cascade of events 
responsible for the calcium and phosphate mineralization in their interior (Lau, Festing et al. 2010). 
Klotho -/- mice secrete less parathyroid hormone (PTH), therefore it is likely that Klotho regulates 
PTH secretion (Yoshida, Fujimori et al. 2002).  
Klotho works with fibroblast growth factors 23 (FGF23) as a required co-factor/co-receptor for the 
activation of FGF receptor. Knockout mice for either Klotho or FGF23 show an inability to activate 
the receptor, resulting in increased expression of co-transporter sodium-phosphate, that causes a 
severe hyperphosphatemia (Kuro-o, Matsumura et al. 1997). Therefore Klotho participates in the 
regulation of the bone-kidney endocrine axis. 
Klotho induces inhibition of insulin/insulin-like growth factor-1 (IGF-1) signalling pathway, which 
has been linked to an extended lifespan in a wide variety of species (Yamamoto, Clark et al. 2005). 
Moreover, the reduction of activation of insulin/IGF-1 signalling induces an increase of the 
forkhead transcription factors (FOXO), that regulate the expression of multiple target genes, 
including antioxidant enzymes such as catalase and mitochondrial manganese-superoxide dismutase 
(SOD2) (Kops, Dansen et al. 2002). The resulting decrement of ROS is linked to increased 
resistance to oxidative stress, which potentially contributes to the anti-aging properties of Klotho. 
Klotho has protective cardiovascular effects and a correlation between plasma’s Klotho level and 
CVD incidence in humans has been reported (Dermaku-Sopjani, Kolgeci et al. 2013). The role of 
Klotho is not only protective, but also predictive of cardiovascular risk. In vitro Klotho protects the 
vessels and the vascular smooth muscle cells (VSMCs) from calcification (Hu, Shi et al. 2011), 
moreover soluble Klotho protects the vascular endothelium (Saito, Nakamura et al. 2000).  
On vascular endothelial cells, Klotho proteins have anti-apoptotic action (in Klotho-treated human 
umbilical vein endothelial cells, caspase-3 and caspase-9 activity decreases) and anti-aging activity 
(by mechanisms involving p53/p21) (Ikushima, Rakugi et al. 2006). The beneficial effect of soluble 
Klotho becomes more relevant when the natural aging process makes vascular endothelial cells 
more susceptible to stress-induced injury: Klotho has protective effect in HUVEC following TNF-α 
induced oxidative stress (Carracedo, Buendia et al. 2012). 
This “anti-aging” molecule may influence various biological processes and the identification of a 
common basis for its pleiotropic function will be of particular importance in understanding its anti-
aging properties. 
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1.3.6 Natural compounds 
Many compounds present in plants and vegetables have the ability to contrast cancer, to drop the 
glucose blood level, to act like antioxidant scavenger and to increase the antioxidant indirect 
defences. 
Polyphenols comprise a wide variety of compounds, divided into several classes (i.e., 
hydroxybenzoic acids, hydroxycinnamic acids, anthocyanins, proanthocyanidins, flavonols, 
flavones, flavanols, flavanones, isoflavones, stilbenes and lignans), that occur in fruits and 
vegetables, wine and tea, chocolate and other cocoa products (Manach, Scalbert et al. 2004). Since 
phenolic compounds are present almost in all fruits, vegetables and other plant products, 
Mediterranean diet, rich of olive oil, fruits, vegetables, whole grains, legumes and nuts is the best 
helper against oxidative stress-related pathologies, in particular neurodegenerative and 
cardiovascular diseases (Widmer, Flammer et al. 2014). 
The so-called “healthy food” owes its name to the presence of nutraceutical compounds, molecules 
rich of properties that may preserve and extend the quality of life. For example, the presence of 
omega-3 fatty acids in Mediterranean diet has positive effects on glucose/insulin homeostasis 
(Bedard, Corneau et al. 2014; Nosova, Conte et al. 2015), resveratrol and other polyphenols widely 
distributed in red wine increase the Glut4 expression (Sun, Zhang et al. 2007). 
Broccoli sprouts and all the plants belonging to the Cruciferous family are rich of sulforaphane 
(SF). SF derives from enzymatic action of myrosinase on glucoraphanin contained in cruciferous 
vegetables (Fahey, Zhang et al. 1997). After 1.5 h consumption of broccoli and other cruciferous 
vegetables, the physiological concentrations of SF measured in vivo range between 0.031 µM to 7.3 
µM (Dinkova-Kostova and Kostov 2012). SF has several documented effects: neuroprotection in 
retina (Pan, He et al. 2014), anti-carcinogenic activity (Fimognari, Turrini et al. 2014), activation of 
cell survival pathways in cardiomyocytes (Leoncini, Malaguti et al. 2011), reduction of oxidative 
stress (Yoon, Kang et al. 2008) and insulin resistance in diabetic patients (Bahadoran, Tohidi et al. 
2012). These effects share a common way of modulation: the Nrf2/Keap1/ARE pathway. In fact, it 
has been demonstrated that SF treatment induced an increase in Prx1 and HO-1 expression and an 
enhancement of the total GSH levels in many cell types. Taken together this evidence suggests that 
SF up-regulates antioxidant defences promoting an hormetic regulation (Cheng, Siow et al. 2011). 
In the last years a “new” natural product has gained increasing interest from nutritional researchers 
and commercial area: Stevia rebaudiana Bertoni, a perennial shrub of Asteraceae (Compositae) 
family, native to subtropical regions of Brazil and Paraguay. 
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This plant has a very sweet taste thanks to glycosides such as stevioside, rebaudioside A, 
rebaudioside C and dulcoside. The leaves contains also β-carotene, thiamine, riboflavin, terpenes, 
and flavonoids (Yadav and Guleria 2012).  
 
 
Stevioside   Rebaudioside A 
 
Fig. 8. Chemical structure of stevioside and rebaudioside A. 
 
Since ancient times, the leaves of Stevia rebaudiana Bertoni were used as a sweetener in Guarani 
Indians of Paraguay and Brazil (Cekic, Vasovic et al. 2011) and for many other medicinal purposes, 
including treatment of diabetes. Nowadays this feature is of particular interest, since metabolic 
disorders, such as type 2 diabetes mellitus and obesity, have become major public health problems 
worldwide (DeFronzo 1988; Zimmet, McCarty et al. 1997). 
A key strategy of glycemic control for prevention and control of diabetes includes monitoring and 
limitation of sugar intake. Stevia leaves and extracts can substitute sucrose, due to their taste 
approximately 200–400 times sweeter than sucrose (Hanson and De Oliveira 1993). 
Results from in vivo animal studies and, at a lesser extent, in humans, suggest that steviosides and 
related compounds affect plasma glucose by modulating insulin secretion and sensitivity (Jeppesen, 
Gregersen et al. 2000; Lailerd, Saengsirisuwan et al. 2004). Moreover, steviosides inhibit 
gluconeogenesis in the liver of diabetic rats (Chan, Wong et al. 2003; Chen, Chen et al. 2005). 
These antihyperglycemic, insulinotropic, and glucagonostatic effects, particularly exhibited by 
rebaudioside A, seem to be largely dependent on plasma glucose level, requiring high glucose levels 
for accomplishment (Jeppesen, Gregersen et al. 2002; Abudula, Matchkov et al. 2008). 
The literature lacks studies elucidating the cellular and molecular mechanisms underpinning these 
effects. It is possible to hypothesize that the compounds present in Stevia leaves could be involved 
in the same transduction pathway of insulin, the PI3K/Akt pathway. This pathway is a key 
25 
 
component of the insulin signalling cascade and it is essential for glucose transport into the cells. 
Upon the binding of insulin to its receptor, the PI3-K/Akt pathway is activated and, among the 
many cellular responses, Glut4 translocates from intracellular pools to the plasma membrane, thus 
enhancing glucose uptake into the cell (Dugani and Klip 2005). 
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2 Aim 
 
Physiological redox signaling refers to processes in which reactive oxygen-, nitrogen- and chlorine-
derived species, collectively called “Reactive Oxidizing Species”, ROS, are produced and employed 
in the intracellular signaling as well as in physiological cross talk between cells, providing a redox 
sensing control of living cell functions. The mechanism at the basis of redox signaling implies the 
interaction of the oxidant species with specific targets, among which the most physiologically 
relevant are thiol/disulfides groups in proteins, with particular regard to those present within 
catalytic or regulatory sites, as well as in receptors, channels and transporters, transcription factors, 
kinases and phosphatases. In redox signaling the reaction of ROS with the target molecules acts as 
an on/off switch signal, resulting in the activation or inhibition of specific intracellular pathways.  
A key point still unsolved is the implications of these cellular products in the regulation of both pro-
survival and cell death pathways. In general terms, basal levels of ROS formation modulate the 
activities of different transcription factors and protein signaling cascades, maintaining proper 
cellular homeostasis and mediating cell proliferation and survival. In contrast, when antioxidant 
defenses are surpassed by ROS formation, an oxidative damage is not repaired by endogenous 
mechanisms, and oxidative stress leads to cell demise. In few words, the redox regulation seems to 
be at the cross road between different programs, regulating cell life and death, thus ROS can be 
considered a double-edged sword. This statement is particularly intriguing considering that several 
proteins, typically involved in physiological redox signaling, could play a key role in the 
determination of cell survival or death, contributing to the development of diseases such as cancer 
and degenerative disorders.  
With this context in mind, three major problems have been investigated and here reported. 
The first one concerns the role of ROS in biosignalling. 
Data from the research group have previously demonstrated that Nox enzymes are a major source of 
ROS in acute leukaemia-derived cell lines and that Nox-derived ROS are required for proliferation 
and survival of these cells, being directly involved in maintaining the high glucose uptake essential 
for cellular aberrant growth (Prata, Maraldi et al. 2008; Maraldi, Prata et al. 2009). 
Since Nox enzymes produce ROS outside the cells and specific aquaporin water channels (AQPs) 
have shown the ability of funnelling H2O2 across the plasma membrane, it was investigated whether 
AQPs could represent one potential way through which H2O2 moves inside these leukemic cells 
behaving like a signal molecule, thus contributing to cell survival and proliferation.  
Other data previously obtained by the research group have shown that in the human leukemic 
B1647 cell line, constitutively producing VEGF, Nox-derived ROS are involved in the 
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autophosphorylation of VEGF receptor 2 (VEGFR-2) and in the modulation of glucose uptake, a 
cellular activity strictly bound to VEGF-induced leukemic cell proliferation (Maraldi, Prata et al. 
2010). 
Since caveolae/lipid rafts are involved in signal transduction and VEGFR-2 and Caveolin-1 (Cav-1) 
have been reported to be frequently co-localized in these domains, it was investigated whether, in 
B1647 cells, VEGFR-2 could be associated with Cav-1 in caveolae/lipid rafts, in order to verify that 
these domains could act as platforms for the modulation of VEGF redox signal transduction 
cascades, leading to glucose uptake and cell proliferation.  
The comprehension of these complex mechanisms could indicate novel potential targets and new 
therapeutic strategies against blood cancer. 
The second faced problem concerns the role of natural or physiological molecules in maintaining or 
altering the ROS balance inside the cells. 
Doctor Siow’s team, at King’s College London, demonstrated that sulforaphane (an isothiocyanate 
present in cruciferous vegetables) mediates pre-activation of the redox sensitive transcription factor 
Nrf2 (nuclear factor erythroid 2-related factor 2) and its downstream target hemeoxygenase-1 (HO-
1) in the cerebral vasculature, protecting the brain against stroke (Alfieri, Srivastava et al. 2013). 
Other data concerning the chemopreventive role of sulforaphane come from studies by our research 
group, which demonstrated that sulforaphane decreased intracellular ROS production, DNA 
fragmentation, and induced the expression of antioxidants and phase II detoxifying enzymes in 
cardiomyocytes, thus exerting a cardioprotective action (Angeloni, Leoncini et al. 2009).  
Due to the pleiotropic role of sulforaphane in increasing the cellular defences against oxidative 
stress, it was investigated whether sulforaphane or Klotho (an endogenous protein endowed with 
multiple pleiotropic effects associated with anti-ageing properties) (Kuro-o 2010) could increase 
antioxidant defences in cultured human aortic smooth muscle cell subjected to high glucose 
conditions mimicking hyperglycaemia. 
This study contributes to elucidate the role of Klotho protein, whose deficiency results in rapid 
ageing in many animal models, and the action mechanism of sulforaphane, a nutraceutical 
antioxidant present in human diet. 
Also the third problem deals with the ROS balance inside the cells, concerning the study of the 
antioxidant and antihyperglycemic properties of natural molecules, since it is well known that high 
blood glucose causes high ROS production, which can lead to diabetes development. 
It has been reported that the leaves of perennial shrub named Stevia rebaudiana Bertoni have 
antioxidant activity both in vitro and in vivo (Shivanna, Naika et al. 2013; Tavarini and Angelini 
2013) and that Rebaudioside A and stevioside (the two main steviol glycosides found in this plant) 
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are the two predominant derivatives used in high potency sweeteners alternative to sucrose. Besides 
sweetness, steviol glycosides have been shown to possess many beneficial effects on human health, 
and a number of animal studies have demonstrated that, in diabetic rats, steviosides exert 
antihyperglycemic and insulinotropic actions (Jeppesen, Gregersen et al. 2002). 
The antioxidant activity of Rebaudioside A and other commercial Stevia extracts was therefore 
investigated in SH-SY5Y and HL-60 cells, furthermore, taking advantage of the group expertise in 
the study of glucose transport activity, the antihyperglycemic properties of these steviosides were 
also studied. The neuroblastoma SH-SY5Y and the promyelocytic leukemia HL-60 cell lines are 
good models for this study, since they both express the Glut1 isoform of glucose transporter, which 
is responsible for the basal glucose uptake, and Glut4, responsible for insulin-stimulated glucose 
uptake in peripheral tissues (Lord, Bunce et al. 1988; van der Heide, Ramakers et al. 2006). 
Furthermore, these cells express also the insulin-like growth factor-1 receptors (IGF-1) (Saltiel and 
Kahn 2001), thereby being susceptible to insulin action.  
Whether the antihyperglycemic and insulinotropic properties of Stevia extracts will be confirmed in 
human cells, the use of these extracts could go beyond their sweetening power, offering also 
therapeutic benefits. 
Part of the experiments concerning the role of Klotho and sulforaphane in cultured human aortic 
smooth muscle cell was performed at the King's College London (Cardiovascular Division, School 
of Medicine) under the supervision of Dr. Richard Siow and thanks to a Marco Polo grant for PhD 
Student’s mobility. 
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3.1 Chemicals and reagents 
Dulbecco’s modified Eagle’s medium (DMEM), foetal calf serum (FCS), penicillin/streptomycin, 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), staurosporine, 2',7'-
dichlorodihydrofluorescein diacetate (H2DCFDA, dichlorofluorescin diacetate), 2-deoxy-glucose 
(DOG), phloretin, CelLytic M, mammalian protease inhibitor mixture, primary antibody to β-actin 
(# A7816), sulforaphane (SF), hydrogen peroxide, bovine serum albumin (BSA), Caspase 3 
Fluorimetric Assay Kit, methyl-β-cyclodextrin (CD), glutathione (GSH), Semaxinib (SU5416), and 
all other chemicals of the highest analytical grade were purchased from Sigma-Aldrich (St. Louis, 
MO, USA). Roswell Park Memorial Institute (RPMI) 1640 medium (with Hepes, with L-glutamine) 
and Iscove's Modified Dulbecco's Medium (IMDM) (with Hepes, with L-glutamine), foetal bovine 
serum (FBS), human serum (HS) were purchased from PAA. 2-deoxy-D-[1,2-3H]-glucose, [1,2-
3H]-cholesterol and Ultima Gold MV scintillation cocktail were from PerkinElmer. PhosSTOP, a 
phosphatase inhibitor cocktail, Bevacizumab were obtained from Roche Diagnostic. VEGF was 
from BioVision (Mountain View, CA, USA). Nitrocellulose membranes and Amersham ECL 
Advance Western Blotting Detection Reagents were from GE-Healthcare. Primary antibodies 
against phospho-Akt (Ser473) (#4058), total Akt (#9272), and horseradish peroxidase-conjugated 
secondary antibodies anti-rabbit (#7074) and anti-mouse (#7076) were purchased from Cell 
Signaling Technologies. Anti-GLUT1 (sc-1603), anti-GLUT4 (sc-1606), and anti-goat IgG 
conjugated to horseradish peroxidase (sc-2020) were obtained from Santa Cruz Biotechnology. 
Primary antibody anti-phospho-PI3 Kinase p85 pTyr458 /p55 pTyr199 (#PA5-17387) was from 
Thermo Scientific. Anti-PI3 Kinase (#06-195) antibody was purchased from Millipore. Anti-AQP1 
(# TA502357-Origene), anti-AQP3 (# SC20811-Santa Cruz), anti-AQP8 (# WH0000343-Sigma-
Aldrich), PageRuler Prestained protein ladder was from Fermentas – Thermo Fisher Scientific. 
Anti-caveolin 1 (# 610059) and anti-transferrin receptor (CD71) (# 612124) antibodies were 
provided by BD Biosciences (San Jose, CA, USA). Anti-Lyn antibody, anti-HO-1 and anti-Prx-1 
antibodies were from Abcam (Cambridge, UK). Anti-VEGF receptor-2 (# 05-554) and anti-P-
tyrosine (# 06–427) were from Millipore (Temecula, CA, USA). Anti-Glut1 (N-20) (# sc-1603) and 
fluorescent FITC-conjugated anti-goat IgG (# sc-2024) were from Santa Cruz Biotechnology (Santa 
Cruz, CA, USA). Recombinant Human Klotho was from Peprotech (# 100-53). Peroxyfluor-1 (PF1) 
was synthesized according to (Miller, Albers et al. 2005). 
Extracts from Stevia rebaudiana Bertoni were kindly supplied by Eridania Sadam SpA. According 
to FDA and EFSA (Goyal, Samsher et al.), total content of steviol glycosides in commercial Stevia 
extracts has to be at least 95% (w/w), and rebaudioside A plus stevioside must be at least 75%. The 
four extracts tested differ by the relative content of rebaudioside A and stevioside. In particular, 
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according to the certificates of analysis of each sweetener, Reb A (R97) contains 97-98% 
rebaudioside A, Stevia RA60 (R60) contains about 60% rebaudioside A and about 20% stevioside; 
Steviol Glycosides SG95 (SG) contains 50% rebaudioside A and at least 25% stevioside; Truvia 
(TRU) contains a mixture of steviol glycosides not analytically quantified. 
 
3.2 Cell Culture  
B1647 is a human acute myeloid leukemia (AML) erythro-megakaryocytic cell line cultured at 
density between 1 × 105 and 1 × 106 cells/mL in IMDM supplemented with 5% human serum (HS), 
2 mM glutamine, 50 U/mL penicillin, and 50 µg/mL streptomycin, at 37 °C in a humidified 
atmosphere maintained at 5% CO2. When indicated, the experimental model employed 16–18 h 
serum-depleted cells, as these conditions were more apt for focusing experiments on self-produced 
VEGF and cholesterol roles, ruling out other growth factor effects. 
HL-60, acute promyelocytic leukaemia cells, were cultured in RPMI-1640 medium supplemented 
with 10% FBS, 2 mM glutamine, 50 U/mL penicillin, and 50 µg/mL streptomycin, at 37 °C in a 
humidified atmosphere maintained at 5% CO2. Cells were maintained at a density between 1 × 105 
and 1 × 106 viable cells/mL, with medium renewal every 2 to 3 days. 
HASMC are aortic smooth muscle cells and were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM) containing 10% (v/v) foetal calf serum (FCS), 2 mM glutamine, 50 U/mL penicillin, and 
50 µg/mL streptomycin at 37 °C in a humidified atmosphere maintained at 5% CO2. Cells were split 
and sub-cultured upon reaching 80-90% confluence by trypsinization, using 1-1.5 mL (0.1%) 
trypsin / (0.02%) EDTA in phosphate buffered saline (PBS). Experiments were conducted between 
passages 4 and 6, in three different conditions: Normal Glucose, NG (5 mM glucose in the culture 
medium DMEM); High Glucose, HG (25 mM glucose in the culture medium DMEM, to mimic an 
hyperglycaemia condition); Mannitol, Man (5 mM glucose + 20 mM mannitol in the culture 
medium DMEM, as osmotic positive control with respect to HG). 
SH-SY5Y, human neuroblastoma cells, were grown at 37 °C in a humidified incubator with 5% 
CO2 in DMEM supplemented with 10% (v/v) foetal bovine serum (FBS), 2 mM glutamine, 50 
U/mL penicillin, and 50 µg/mL streptomycin. Cells were split and sub-cultured upon reaching 80-
90% confluence by trypsinization, using 1-1.5mL 1% trypsin in PBS. Experiments were conducted 
between passages 16-21. 
All procedures, sub-culturing, treating of the cells and preparation of all treatment reagents were 
handled under sterile aseptic techniques in a Class 2 laminar flow safety cabinet. 
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Table 1. Cells were sub-cultured up in T75 flasks or in a Petri’s dishes, after which they were seeded into 
96-well plates, 24-well plates, 12-well plates, 6-well plates or T25 flasks for subsequent experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3 Cell Viability 
Viable cells were evaluated by the Trypan blue exclusion test. Cell viability was also assayed by the 
MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) assay. 
The MTT assay developed by Mosmann is a quantitative colorimetric assay, which detects living 
cells, and the signal generated is dependent on the degree of mitochondrial dehydrogenase activity 
(Mosmann 1983). MTT can only be cleaved by active mitochondrial enzymes in living cells and the 
assay measures the activity of NAD-dependent dehydrogenase enzymes; it can also be used to 
assess the cytotoxic effects of drugs (Gerlier and Thomasset 1986). 
Twenty-four hours after seeding adherent cells into the 96-well plate, they were subjected to the 
different treatments. Then, the medium was aspirated and replaced with 100 µL of MTT (0.5 
mg/mL) in medium and cells were incubated at 37 °C and 5% CO2 under sterile conditions for 2h. 
Then, DMSO (50 µL) was added to each well and the purple/brown crystals of formazan formed 
were dissolved by placing the plate on a shaker (room temperature) for approximately 10 min. 
Vessel 
Cells at 
Confluency 
Trypsin 
or lysis 
buffer 
vol 
(mL) 
Growth 
Medium 
(mL) 
Dishes 
Petri's 
Dishes 
1 x 106 1 6 
Culture Plates 
6-well 0.2 x 106 0.2 2 
12-
well 
0.1 x 106 0.1 1 
24-
well 
0.05 x 106 0.5 0.5 
96-
well 
0.02 x 106 0.01 0.2 
Flasks 
T-25 0.7 x 106   12 
T-75 2.1 x 106   30 
T-160 4.6 x 106   60 
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Suspended cells were centrifuged after treatments and re-suspended in a medium solution contained 
MTT (0.5mg/mL) for 2h, formazan salt crystal formed were dissolved by adding the solubilization 
solution (10% SDS-1% HCl). 
The absorption at 570 nm was measured on a multiwell plate reader (Wallac Victor2, PerkinElmer). 
The average absorbance reading of octuplicate treatments was calculated and analysis of cell 
viability was based on percentage change from the control for each treatment. 
 
3.4 Lactate dehydrogenase assay 
Lactate dehydrogenase (LDH) activity was assayed by a spectrophotometric method based on the 
reduction of pyruvate to lactic acid coupled to NADH oxidation. The decrease in absorbance at 340 
nm was monitored at 37 °C. 100 µM H2O2 for 30 minutes was used as a positive control. 
- SH-SY5Y and HL-60 cells were incubated with 1 mg/mL of each Stevia extract for 24 h. LDH 
release from cells was monitored by collecting aliquots of medium. 
 
3.5 Assay for caspase 3 activity 
Caspase 3 activity in the cell lysates was measured using a fluorimetric assay kit by following the 
instructions from the manufacturer (Sigma). After treatments, cells were collected and lysed using 
the lysis buffer provided in the kit (250 mM HEPES, pH 7.4 containing 25 mM CHAPS and 25 mM 
DTT). The assay was based on the hydrolysis of the peptide substrate acetyl-Asp-Glu-Val-Asp-
aminomethylcoumarin (Ac-DEVD-AMC) by caspase 3, resulting in the release of free AMC 
moiety. The fluorescence of AMC was read using a multiwell plate reader (Wallac Victor2, 
PerkinElmer); excitation and emission wavelengths were 360 nm and 460 nm, respectively. 
The concentration of the AMC released was calculated using an AMC standard curve. Caspase 3 
activity was expressed in nmole of AMC released per min per mL of cell lysate and normalised for 
total protein content in the lysate. Results are reported as percentage in respect to the control. 
Staurosporine (1 µg/mL) was used as an apoptosis inducer (positive control). 
- SH-SY5Y and HL-60 cells were incubated with or without steviol glycosides (1 mg/mL) for 1, 6 
or 24h. After, the samples were collected using the kit’s buffer and processed as previously 
described. 
 
3.6 Measurement of intracellular reactive oxidizing species (ROS) levels 
ROS intracellular level was evaluated by using the fluorescent probe 2',7'-
dichlorodihydrofluorescein diacetate (H2DCFDA). At the end of each time-point treatments, cells 
were washed twice in PBS and incubated with 5 µM H2DCFD for 20 min at 37 °C. H2DCFDA is a 
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small non-polar, non-fluorescent molecule that diffuses into the cells, where it is enzymatically 
deacetylated by intracellular esterases to a polar non-fluorescent compound, that is oxidised to the 
highly green fluorescent 2',7'-dichlorofluorescein (DCF). The fluorescence of oxidized probe was 
measured using a multiwell plate reader (Wallac Victor2, PerkinElmer). Excitation wavelength was 
485 nm and emission wavelength was 535 nm. Fluorescence values were reported as the percentage 
of intracellular ROS in respect to controls. 
- B1647 were incubated with 5 µM AgNO3 for 10 min, then 10 or 100 µM H2O2 was added to the 
cells. After the overexpression of AQP1, AQP3, AQP8 cells were treated or not with 100 µM H2O2 
for 10 min. 
- SH-SY5Y and HL-60 cells were incubated with 5 mg/mL of each Stevia extracts for 1 or 24h, then 
subjected or not to oxidative stress generated by 100 µM H2O2 for 30 min. 
Hydrogen peroxide level was also determined in B1647 cells by using Peroxyfluor-1 (PF1). PF1 is 
a fluorescent boronate probe, selective for H2O2, although less sensitive than H2DCFDA. The 
fluorescence of the oxidized probe was measured on a multiwell plate reader (Wallac Victor2, 
Perkin Elmer) at excitation and emission of 485 nm and 535 nm, respectively. Fluorescence values 
were reported as the percentage of intracellular H2O2 with respect to controls. 
- B1647 cells (1 × 106 cells/mL) were washed twice in HBSS and incubated with 10 µM PF1 for 20 
min at 37 °C, in the dark. Then, the cells were washed three times in HBSS and pre-treated with 5 
µM AgNO3 for 10 min, then 100 or 200 µM H2O2 was added to the cells and the fluorescence was 
determined after 10 min. 
 
3.7 Glucose transport assay 
Glucose transport assay was performed as previously described (Hrelia, Fiorentini et al. 2002; 
Fiorentini, Prata et al. 2004). Adherent cells (SH-SY5Y) were seeded at density of 16.6 × 104. After 
treatments with different compounds, they were washed twice in PBS and treated for 10 min at 37 
°C with a mixture (named as DOG mixture) of 2-deoxy-D-[1,2-3H] glucose (0.8 µCi/assay) and 1.0 
mM unlabeled glucose analogue; under these conditions the uptake was linear at least for 20 min 
(zero-trans conditions). The transport was stopped by adding phloretin (final concentration 0.3 
mM), a potent inhibitor of glucose transport activity. Cells were scraped adding cold PBS and 
centrifuged at 4000 g for 1 min. The pellet was resuspended in 3 mL Ultima Gold MV scintillation 
cocktail and the radioactivity was measured by liquid scintillation counting (Tri-Carb® liquid 
scintillation analyser, PerkinElmer). 
Suspended cell (HL-60 or B1647) were utilized at 4 × 106 cells/mL in PBS. They were incubated 
with different stimuli and/or inhibitors at 37 °C and then treated with a mixture (named as DOG 
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mixture) of 2-deoxy-D-[1,2-3H] glucose (0.4 µCi/assay) and 1 mM unlabelled glucose analogue for 
2 min at 37 °C. After this time, the uptake was stopped by adding phloretin (final concentration, 0.3 
mM). Cell were washed with PBS and resuspended in 3 mL Ultima Gold MV scintillation cocktail. 
Sample radioactivity was measured by liquid scintillation counting (Tri-Carb® liquid scintillation 
analyser, PerkinElmer). 
 
3.8 Cell transfection 
The transfection was done using Cell Line Nucleofector™ Kit V (Amaxa® Biosystems, Cologne, 
Germany). 2 × 106 cells was resuspended in 100 µL Nucleofector® Solution at room-temperature, 
then 2 µg DNA or 2 µg pmaxGFP® Vector (positive control for overexpression) were added to the 
suspension, or 300 nM siRNA. This suspension was transferred into an Amaxa® certified cuvette 
(sample must cover the bottom of the cuvette without air bubbles). Cells was electroporated using 
appropriate Nucleofector® Program. Immediately, ~500 µL of culture medium, pre-equilibrated at 
37 °C, were added to the cuvette and the sample was gently transferred into 6-well plate. Cells were 
maintained at 37 °C/5% CO2 for 24 or 48h and after this period treatments were done. 
- B1647 cells were nucleofected with Cell Line Nucleofector™ Kit V (Amaxa® Biosystems, 
Cologne, Germany) with Program T-019 following the manufacturer's instructions; plasmid vectors 
pCMV6-XL4 or pCMV6-XL5 for the overexpression of AQP1 (NM_198098), AQP3 
(NM_004925) and AQP8 (NM_001169) were obtained from Origene (Rockville, USA). 
For silencing, siRNA against AQP3 (Duplex sequence: GAGCAGAUCUGAGUGGGCA [dT][dT]; 
UGCCCACUCAGAUCUGCUC [dT][dT]), AQP8 (Duplex sequence: 
CUGCUCAUUAGGUGCUUCA [dT][dT]; UGAAGCACCUAAUGAGCAG [dT][dT]) and 
random RNA sequence (scrambled, as negative control) were obtained from Sigma-Aldrich. After 
24 or 48h, cells were used for the experiments: cell viability assays, evaluation of AQP1, AQP3, 
and AQP8 expression by Western blotting, and transfection efficiency. 
 
3.9 Immunoblotting analysis 
- Preparation of whole cell lysates 
On completion of a given treatment, cells were washed twice with cold non-sterile PBS and then 
lysed by the addition of buffer containing 2% sodium dodecyl sulphate (SDS), 10% glycerol, 50 
mM Tris base, protease inhibitor cocktail (1:1000) and phosphatase inhibitors I and II (1:2000). 
Whole cell lysates were collected after 10 min incubation on ice and stored at -20°C for subsequent 
analysis. 
- Preparation of cytosolic cell lysates 
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Following completion of the treatment period, cells were washed with ice-cold PBS and lysed on 
ice using CelLytic M containing mammalian protease and phosphatase inhibitor mixture. 
The resulting lysed cells were left on ice to solubilize for 15 min. The lysates were centrifuged at 
5000 g for 5 min at 4 °C to remove unbroken cell debris and nuclei and supernatants containing the 
cytosolic fraction were collected and stored at -80°C. 
 
- Protein assay 
Cell lysate protein concentration was colorimetrically determined by the Bio-Rad Bradford 
Coomassie Blue protein assay (Bio-Rad Laboratories) with bovine serum albumin (BSA) as 
standard (Bradford 1976). Since elevated concentration of detergents (such as Triton X-100 and 
SDS) interferes with Coomassie Blue reagent, protein concentration of fractions obtained from 
sucrose gradient or sample for Western blotting was determined by the Bio-Rad DC protein assay 
kit (Bio-Rad Laboratories), using BSA as a standard in the presence of appropriate concentration of 
Triton X-100 or SDS or lysis buffer. For the experiments carried out at King’s College, 
bicinchoninic acid (BCA) protein concentration assay was used. This highly sensitive method was 
firstly described by Smith (Smith, Krohn et al. 1985). This colorimetric assay depends on the 
reduction of Cu2+ to Cu+ by peptide bonds in protein under alkaline conditions and can be used for 
determining protein concentrations of unknown samples by comparing absorbance at 562 nm 
relative to a standard curve of known protein concentrations. Standards and samples were prepared 
in triplicate. Lysis buffer was added to the standards at a 1:1 ratio and double-distilled water was 
added to each sample at 1:1 ratio. Once aliquoted into the 96-well plate, the BSA standards and 
samples were incubated with 200 µL of BCA reagents mixture (reagent A: reagent B = 50:1, 
Thermo Scientific, UK) at 37 °C for 25 min. The sample absorbance at 562 nm was then measured 
using a microplate spectrophotometer (Tecan Sunrise). 
 
- SDS-PAGE and Western blot analysis 
After determining protein concentration, the volume required to provide 10 µg of protein sample 
was determined and aliquoted into separate Eppendorf tubes containing reducing loading buffer 
(0.02% bromophenol blue + 2% 2-mercaptoethanol). The negatively charged protein extracts were 
denatured at 95 °C for 3 min prior to loading onto a sodium dodecyl sulfate – polyacrylamide gel 
(SDS-PAGE), 10% SDS-PAGE Mini-Protean® TGX™ precast gels using a Mini-Protean apparatus 
(Bio-Rad Laboratories). Samples were loaded alongside 4 µL PageRulerTM protein ladder 
(Fermentas, USA) to enable identification of proteins of interest and electrophoretically transferred 
to nitrocellulose membrane (Hybond-C; GE Healthcare) or PVDF membrane (for the experiments 
42 
 
set at King’s College) in Tris-glycine buffer at 110 V for 90 min. Non-specific binding to 
membrane was blocked by incubating in Tris-buffered saline (TBS)/Tween, pH 8.0, containing 5% 
non-fat dried milk or BSA for 1 hour at room temperature. Blots were probed overnight at 4 °C with 
primary antibodies, washed with TBS/Tween and then incubated for 1 hour at room temperature 
with secondary horseradish peroxidase conjugates antibodies. Membranes were washed and the 
antigens were then visualized by addition of ECL Plus Western Blotting Detection Reagents. 
Images of the blots were obtained using a CCD imager (ChemiDoc MP System, Bio-Rad) and 
bands were acquired and analysed by using Image Lab analysis software; for the experiments set at 
King’s College, membrane was detected using the Genesnap G-box and software Syngene, and data 
obtained was analysed using densitometry software Image J. 
 
Table 2. Table of primary antibody. 
Antigen 
Species 
(antibody raised in) Dilution Supplier 
α-tubulin Rat 1:5000 Millipore 
β-actin Mouse 1:5000 Sigma-Aldrich  
HO-1 Rabbit 1:500 Abcam 
Prx-1 Rabbit 1:500 Abcam 
flotillin-2  Rabbit 1:1000 Sigma-Aldrich  
phospho-Akt  Rabbit 1:1000 Cell Signaling Technology 
Akt Rabbit 1:1000 Cell Signaling Technology 
GLUT1 (C-20 and N-20) Goat 1:1000 Santa Cruz 
GLUT4 Goat 1:1000 Santa Cruz 
PI3 Kinase  Rabbit 1:1000 Millipore 
phospho-PI3K Rabbit 1:1000 Millipore 
AQP1  Rabbit 1:1000 Santa Cruz 
AQP3 Rabbit 1:1000 Santa Cruz 
AQP8 Rabbit 1:1000 Santa Cruz 
caveolin 1 Rabbit 1:1000 BD Biosciences  
transferrin receptor (CD71) Rabbit 1:1000 BD Biosciences  
Lyn  Rabbit 1:1000 Abcam 
VEGF receptor-2  Rabbit 1:1000 Millipore 
phospho-tyrosine  Rabbit 1:1000 Millipore 
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Table 3. Table of secondary antibody. 
 
Dilution Supplier 
Rabbit monoclonal 
HRP conjugated 1:10000 Cell Signaling Technology 
Mouse monoclonal 
HRP conjugated 1:10000 Cell Signaling Technology 
Donkey anti-goat 
HRP conjugated 1:5000 Santa Cruz 
Donkey anti-goat 
FITC-conjugated 1:500 Santa Cruz 
Rat monoclonal 
HRP conjugated 1:10000 Millipore 
 
All antibody were diluted in 5% BSA or non-fat dried milk in PBS/0.1% Tween. 
 
3.10 Cholesterol depletion 
Cyclodextrins are cyclic oligomers of glucose that have the capacity to sequester lipophilic 
molecules in their hydrophobic core (Pitha, Irie et al. 1988). It has been shown that β-cyclodextrins 
remove cholesterol from cultured cells (Ohtani, Irie et al. 1989; Kilsdonk, Yancey et al. 1995), and 
among the different dextrin derivatives, methyl-β-cyclodextrin (CD) was shown to be the most 
efficient as acceptor of cellular cholesterol, and the most commonly used (Klein, Gimpl et al. 1995; 
Zidovetzki and Levitan 2007). Therefore, methyl-β-cyclodextrin was chosen to induce cholesterol 
depletion from plasma membrane of B1647 cells, and experiments were performed to set the 
desired conditions, as the degree of cholesterol depletion is a function of the β-cyclodextrin 
derivative concentration, incubation time, temperature and cell type subjected to the treatment 
(Christian, Haynes et al. 1997). 
B1647 cells suspended in culture medium were incubated overnight with [3H]-cholesterol (0.5 
µCi/mL), then washed, suspended in PBS and exposed to different concentrations of CD (2.5 to 25 
mM) for different incubation times (0–40 min). To measure the relative cholesterol content, cells 
were washed twice in PBS, pelleted at 4.000 g for 1 min and sample radioactivity was quantified by 
liquid-scintillation counting (Tri-Carb® liquid scintillation analyzer, PerkinElmer). 
 
3.11 Isolation of membrane caveolae/lipid rafts 
Caveolae/lipid rafts (DRM, detergent resistant membranes) and detergent-soluble membrane 
domains were separated by flotation assays adapted from previously described methods (Caliceti, 
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Zambonin et al. 2012). 200 × 106 B1647 cells (approx. 6 mg of protein) were washed twice with 
PBS, pelleted at 300 g for 7 min and left on ice for 10 min. The cell pellet was incubated at 4 °C in 
1.2 mL of lysis buffer (1% Triton X-100, 150 mM NaCl, 50 mM Tris and 5 mM EDTA 
supplemented with 0.1 mM PMSF, 0.1 mM TLCK, 0.1 mM TPCK, 1 mM orthovanadate and 
protease inhibitor cocktail, pH 8.0). In all subsequent steps, solutions and samples were kept at 4 
°C. The lysates were then spun for 10 min at 6.000 g in an Eppendorf Microfuge and supernatants 
were homogenized in a Potter homogenizer with 20 strokes. For sucrose gradient separations, 1.0 
mL of 80% sucrose prepared in PBS was mixed with an equal volume of homogenized sample and 
then overlaid with a 5–40% sucrose linear step gradient (1.3 mL each of 5%, 30% and 40% sucrose 
in PBS). After centrifugation in a SW50.1 Beckman rotor at 160.000 g for 18 h at 4 °C, nine 500 µL 
fractions were collected from the top of the gradient. Equal volume aliquots of each fraction was 
added with Laemmli buffer containing both mercaptoethanol and bromophenol blue and boiled for 
3 min. Samples were then subjected to SDS-PAGE and immunoblotting. 
This detergent-based fractionation on sucrose-density gradient isolate buoyant lipid rafts and 
caveolae (a subset of lipid rafts, flask-like invaginations of the plasma membrane with lipid 
composition similar to rafts and expressing a coat of caveolin proteins on the inner leaflet of the 
membrane bilayer (Razani, Woodman et al. 2002) but it is not able to discriminate between rafts 
and caveolae. Caveolin antibody-based immunoisolation of detergent-insoluble membranes 
selectively isolates caveolae and not lipid rafts, pulling down also the caveolar lipids, cholesterol, 
and associated proteins. 
 
3.12 Immunoprecipitation 
Following completion of the treatment period, cells were lysed using a lysis buffer (the same used 
for Western Blot). Lysates containing equal protein amounts were incubated overnight with the 
specific antibody for the protein chosen for the immunoprecipitation (VEGFR-2). Subsequently 
samples were incubated with protein G-Sepharose beads for 1.5 h at 4  °C and then pelleted. Pellets 
were washed four times with lysis buffer, treated with reducing buffer containing 4% 2-
mercaptoethanol and boiled for 3 min. Samples were then subjected to SDS-PAGE and 
immunoblotting with primary antibodies (anti-caveolin-1, anti-phospho-tyrosine, or anti-VEGFR-
2). 
 
3.13 Immunofluorescence 
B1647 cells (2 × 106) were incubated for 20 min with or without 10 mM CD, then pelleted, washed 
with PBS to remove culture medium, and fixed in 3% (w/v) paraformaldheyde for 15 min. Cells 
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were washed twice with HBSS, blocked with PBS/BSA 3% (w/v) for 1 hour at room temperature, 
washed 3 times, and then overnight incubated at 4 °C with 20 µg/mL of anti-Glut1 raised against a 
peptide within an extracellular domain of the human transporter protein (N-20). Cells were then 
treated for 1 hour at room temperature with fluorescent FITC-conjugated rabbit anti-goat IgG, 
mounted on slides and visualized using an Olympus IX50 microscope. 
 
3.14 Real-time impedance-based used for detecting cell proliferation 
Measurements of cell proliferation were performed using the iCELLigence Real-Time Cell 
Analyzer DP (Roche Applied Science, Indianapolis, IN) inside a cell culture incubator. 
The iCELLigence system is a impedance-based system for cell-based assays, allowing for label-free 
and real-time monitoring of cellular processes such as cell growth, proliferation, cytotoxicity, 
adhesion, morphological dynamics (like contraction) and modulation of barrier function. The 
system is composed of an electronic analyzer that fits inside the cell culture incubator, and an iPad 
which runs the software and operates the entire system in a wireless mode. At the core of the system 
are electronic plates (E-Plates L8) that have integrated microelectrode sensors in the bottom of the 
wells. The presence or absence of cells sensitively and precisely affects the electronic and ionic 
exchange between cell culture media and the microelectrodes when an electric field is applied to the 
system. Changes in electrical impedance reflect the biological status of the cells, thus the system 
allows monitoring of time-dependent perturbation effects in a tissue culture environment, providing 
dynamic information and a unique approach to cell-based assays. 
Cell index is the unit measure of cell impedance and normalized cell index is the cell index value at 
a time point divided by value of cell index at an earlier starting or reference point. Impedance was 
collected every 15 minutes for proliferation assays. 
Cells are seeded at a density of 5×104 cells/well on an specific E-plate 8 (Roche Applied Science) in 
10% FBS growth medium. All controls and treatments in these experiments were performed in 
duplicate. 
- HASMC were seeded on E-plate 8 and treaded with 3 different Klotho concentrations (0.1; 0.5; 1 
nM). Growth and proliferation were monitored for 48h. 
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3.15 Fluorescent assay for intracellular Glutathione (GSH) content 
Glutathione (GSH) is a tri-peptide ubiquitously expressed in all cell types and it represents the 
major non-enzymatic regulator of intracellular redox homeostasis (Masella, Di Benedetto et al. 
2005). 
Cells were seeded in 24-well plates. After different treatments, cells were washed twice with ice-
cold PBS, and cold 6.5% trichloroacetic acid (TCA) was added to the wells and left for 10 min on 
ice. TCA is widely used for the precipitation of proteins (Witt and Roskoski 1975), and in this case 
it was used for the extraction of GSH. After deproteinization, the supernatant was transferred into 
Eppendorf tubes; 7.5 µL was incubated with 277.5 µL of sodium phosphate buffer at pH 8.0 
containing 5 mM EDTA and 15 µL of o-phthalaldehyde (OPA; 1 mg/mL in methanol) for 25 min at 
room temperature in a black 96-well plates. OPA is a fluorogenic reagent that reacts with primary 
amines and in the presence of thiol it yields an intense blue colored fluorescent product; the assay 
provides a rapid and very sensitive method for determining reduced GSH. 
Fluorescence intensity was then measured at an excitation wavelength of 340 nm and an emission 
wavelength of 420 nm in a Hidex plate reader (Chameleon V, Hidex). The GSH content was 
calculated using a GSH standard curve, and expressed as nanomoles of GSH per milligram of 
protein. 
After the supernatant removal from the 24-well plates, NaOH was added to each well to collect 
protein lysates for determination of the cellular protein concentration using the BCA assay 
(previously described). 
- HASMC were plated into 24-well plates at a density of 5×104 cells/well. After 24 h growth, 
treatments were carried out. Total content was assessed in normal glucose, high glucose and 
mannitol conditions, after 12 and 24h treatment with 2.5 µM-5 µM sulforaphane or after 8 and 24h 
treatment with 0.1-0.5-1 nM Klotho. 
 
3.16 Statistical analysis 
Results are expressed as means ± SD or means ± SEM. Differences among the means were 
determined by Bonferroni’s multiple comparison test following one-way ANOVA. 
  
47 
 
 
 
 
 
 
Chapter 4- Results 
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4.1 Redox Signalling in Human Leukaemia Cells: Role of Aquaporins  
As previously stated, it has been shown that specific aquaporin isoforms facilitate the passive 
diffusion of H2O2 across biological membranes, controlling H2O2 membrane permeability and 
signaling in living organisms (Bienert and Chaumont 2014). 
In particular, three AQP isoforms have been reported to channel H2O2 across the plasma membrane: 
AQP1, AQP3, widely expressed in blood cells, and AQP8, expressed in primitive erythroid cells 
(Vieceli Dalla Sega, Zambonin et al. 2014). 
The aim of this study was to investigate the role of AQP isoforms in human cell lines derived from 
acute myeloid leukaemia, in order to verify whether, also in these cells, AQPs could represent one 
potential way through which H2O2, produced by Nox enzymes, moves inside the cells behaving like 
a signal molecule, thus contributing to cell survival and proliferation.  
Our research group has previously reported that Nox enzymes are a major source of ROS in acute 
leukaemia-derived cell lines and that Nox-derived ROS are required for proliferation and survival 
of these cells, being directly involved in maintaining the high glucose uptake essential for cellular 
aberrant growth (Prata, Maraldi et al. 2008; Maraldi, Prata et al. 2010). 
Experiments were performed in a erythro-megakaryocytic human cell line, B1647, focusing the 
attention on AQP1, AQP3 and AQP8. 
 
4.1.1 Evaluation of the effect exerted by AQP inhibition on intracellular ROS level 
Powerful tools to study the involvement of a protein in a biological process or disease are the 
pharmacological inhibition of its activity or the gene deletion/silencing. When an inhibitor is used, 
it should be characterized by high specificity and affinity, but unfortunately these compounds are 
often unspecific, due to several off-target effects or the inhibition of features that are not unique for 
the target enzyme. As far as AQP transporters are concerned, it has been reported that silver ions 
are potent and specific inhibitors of AQP activity, acting by binding to cysteine or histidine residues 
in the region of the channels (Vieceli Dalla Sega, Zambonin et al. 2014). Thus, the effect of AgNO3 
was investigated, and preliminary experiments were performed in order to test its potential 
cytotoxicity in B1647 cell line. 
Cells were treated with different AgNO3 concentrations for 10 min and the viability was evaluated 
by using MTT assay as reported in Material and Methods section (Fig.1A). The results show that 
treatment with AgNO3 did not affect B1647 cell viability up to 10 µM, thus we chose 5 µM AgNO3 
for the subsequent experiments. 
Cells treated with 5 µM AgNO3 for 10 min were then exposed to 10 µM or 100 µM H2O2. 
Intracellular ROS level was evaluated spectrofluorimetrically by means of H2DCFDA probe (as 
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reported in Material and Methods). As shown in Fig. 1B, cells treated with AgNO3 exhibited a 22% 
decrease in the basal intracellular ROS level compared to control cells. The role of extracellular 
H2O2 in triggering DCF fluorescence is confirmed by the observation that the treatment with 
extracellular 5 mg/mL catalase abrogated the effect of AQP inhibition on the basal intracellular 
ROS level. When cells were externally added with 10 µM or 100 µM H2O2, a significant 
fluorescence increase was observed, while cells pre-incubated with AQP inhibitor exhibited a 35% 
and 19% decrease in fluorescence compared to the cells spiked with H2O2 10 µM or 100 µM, 
respectively. 
In order to confirm that intracellular ROS level is mainly due to hydrogen peroxide, H2O2 level was 
also measured by using PF1, a fluorescent boronate dye endowed with high selectivity for H2O2 
over similar ROS, such as superoxide anion and hypochlorite ion (Chang, Pralle et al. 2004). After 
the treatment with AgNO3, cells were incubated with 100 µM or 200 µM H2O2, as shown in Fig. 
1C. The trend of the experiment obtained with the PF1 probe is very similar to that obtained with 
the H2DCFDA probe reported in Fig. 1B, confirming that H2O2 is the main intracellular ROS. 
Unfortunately, although PF1 is a useful tool owing to its selectivity towards H2O2, it is not sensitive 
enough to evaluate possible changes in basal intracellular H2O2 level (Miller and Chang 2007). 
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Fig. 8. Effect of AgNO3 on viability and on intracellular ROS level in B1647 cells.  
(A) Cells were incubated with different concentrations of AgNO3 (1-50 µM) and their viability was evaluated by using 
MTT assay as reported in Material and Methods. Data are expressed as % of Control and represent means ± SD of at 
least three independent experiments. Data were analysed by one-way ANOVA followed by Bonferroni's test: ***p < 
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0.001 significantly different from Control. (B) Cells were incubated with 5 µM AgNO3 and then treated with 10 or 100 
µM H2O2. Intracellular ROS level was evaluated as H2DCFDA fluorescence as reported in Material and Methods. In 
the experiment with 5 mg ⁄mL catalase, the enzyme was added prior to AgNO3 treatment. Data are expressed as % of 
Control and represent means ± SD of at least three independent experiments. Data were analysed by one-way ANOVA 
followed by Bonferroni's test: *p < 0.05 significantly different from Control; §p < 0.05 significantly different from cells 
treated with 10 µM H2O2; °p < 0.05 significantly different from cells treated with 100 µM H2O2. (C) Cells were 
incubated with 5 µM AgNO3 and then treated with 100 or 200 µM H2O2. Intracellular ROS level was evaluated as PF1 
fluorescence as reported in Material and Methods. Data are expressed as % of Control and represent means ± SD of at 
least three independent experiments. Data were analysed by one-way ANOVA followed by Bonferroni's test: *p < 0.05 
significantly different from Control; §p < 0.05 significantly different from cells treated with 100 µM H2O2; °p < 0.05 
significantly different from cells treated with 200 µM H2O2. 
 
4.1.2 Study of the correlation between Nox-generated ROS and AQP activity 
The single or combined effect of Nox and AQP inhibition could help to understand their mechanism 
of action and to investigate the correlation between their functions. Several small molecules have 
been and are still being used as direct NADPH oxidase inhibitors. The most frequently used Nox 
inhibitors are diphenylene iodonium (DPI) and apocynin, although they have been proved to be 
unspecific. DPI acts as a general flavoprotein inhibitor and, therefore, also inhibits eNOS, xanthine 
oxidase, and proteins of the mitochondrial electron transport chain. Apocynin shows intrinsic 
antioxidant activity, that is, ROS-scavenging properties (Altenhofer, Radermacher et al. 2014). 
Since many previously data in B1647 cell line were obtained with DPI, this inhibitor was chosen to 
perform the subsequent experiments. 
B1647 cells were pre-incubated with DPI and then treated with AgNO3. Intracellular ROS level was 
evaluated spectrofluorimetrically by means of H2DCFDA probe (as reported in Materials and 
Methods section). As shown in Fig. 2A, a decrease in intracellular ROS level was observed after the 
pre-treatment with 10 µM DPI for 30 min. The treatment with both the inhibitors, AgNO3 and DPI, 
caused a decrease in intracellular ROS level, but their effect was not additive, suggesting that they 
act by two different ways. 
Evidence so far described allows to speculate that, in B1647 cell line, Nox-produced H2O2 outside 
the cell could cross the plasma membrane via AQP channel, thus acting as signal molecule. 
Therefore, the measure of a cellular activity linked to this signalling pathway could strengthen this 
hypothesis. 
Data obtained in our lab have previously demonstrated that H2O2 mimics the growth factor 
stimulation of glucose uptake in leukaemia cell lines, suggesting a key role for ROS in the 
signalling leading to Glut1 regulation (Maraldi, Fiorentini et al. 2007). In B1647 cells, VEGF is 
supposed to utilize ROS as messenger intermediates downstream of the VEGF-receptor 2, and 
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glucose uptake is considered a model of cellular activity strictly bound to VEGF-induced cell 
proliferation. In this cell type, antioxidants and Nox inhibitors (DPI and apocynin) induce a similar 
decrease in the glucose uptake rate (Maraldi, Prata et al. 2007). Therefore, the effect of AQP 
inhibition on glucose transport in B1647 cells was assessed by means of a radioisotopic assay as 
reported in Material and Methods section. Cells were incubated with 5 µM AgNO3 for 10 min and 
the results are shown in Fig. 2B. It can be seen that AgNO3 treatment caused a 32% decrease in 
glucose transport compared to the control cells. In agreement with data on intracellular ROS level, 
the simultaneous treatment with DPI and AgNO3 did not cause an additive effect on glucose uptake 
(Fig. 2B). 
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Fig. 9. Effect of AQP and Nox inhibition on intracellular ROS level and glucose transport in B1647 cells. 
(A) Cells were incubated with 5 µM AgNO3 and then treated with 10 µM DPI for 30 min. Intracellular ROS level was 
evaluated as DCF fluorescence as reported in Material and Methods. Data are expressed as % of Control and represent 
means ± SD of at least three independent experiments. Data were analysed by one-way ANOVA followed by 
Bonferroni's test: *p < 0.05 significantly different from Control. (B) Cells were incubated with AgNO3 and then treated 
with 10 µM DPI for 30 min. Glucose uptake was evaluated by means of a radioisotopic assay as reported in Material 
and Methods. Data are expressed as % of Control and represent means ± SD of at least three independent experiments. 
Data were analysed by one-way ANOVA followed by Bonferroni's test: *p < 0.05 significantly different from Control. 
 
4.1.3 Evaluation of the effect exerted by AQP silencing on intracellular ROS level  
Gene silencing is considered a gene knockdown mechanism since the methods used to silence genes 
generally reduce the expression of a gene but do not completely eliminate it. Gene silencing is 
usually more specific than the use of inhibitors, therefore this technique was chosen to support data 
obtained with AgNO3.  
Specific siRNA were used to silence AQP1, AQP3 and AQP8 isoforms, as described in Materials 
and Methods section. 
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First of all, constitutive expression of the target isoforms was established by Western Blotting 
analysis, using specific antibodies against AQP1, AQP3 and AQP8. As it can be seen in Fig. 3A, 
B1647 cell line does not express AQP1, while the constitutive AQP3 and AQP8 isoforms are 
clearly evident. For this reason, only AQP3 and AQP8 isoforms were silenced. 
 
       
 
Fig. 10. Expression of AQP isoforms in B1647 cells. 
(A) Constitutive expression of AQP isoforms in B1647 cells. The images show a representative experiment out of three 
independent analyses. (B) B1647 cells were transfected by electroporation with siRNA against AQP3, AQP8 or a 
random RNA sequence (scrambled) as negative control as described in Materials and Methods. Effect of RNA 
interference on the target isoforms was confirmed by Western blot with specific antibodies against AQP3 or AQP8. The 
images show a representative experiment out of three independent analyses. 
 
B1647 cells were then transfected by electroporation with siRNA against AQP3, AQP8 or a random 
RNA sequence (scrambled) as negative control and the effect of this procedure was confirmed by 
Western Blotting analysis, as shown in Fig. 3B. The viability of the transfected cells was assayed by 
means of both the Trypan Blue exclusion test and the MTT test, indicating that this treatment does 
not affect cell viability (data not shown). 
Then the effect of AQP3 and AQP8 silencing was evaluated on intracellular ROS levels (Fig. 4). 
The results in Fig. 4A show that basal ROS level was significantly reduced only by silenced AQP8. 
On the other hand, when cells were stimulated with the addition of H2O2, both the silenced isoforms 
were able to cause a significant decrease in DCF fluorescence, although AQP3 siRNA in a lesser 
extent compared to AQP8 siRNA.  
In order to corroborate also the data obtained in condition of Nox inhibition, the effect of DPI on 
intracellular ROS level was evaluated after AQP3 and AQP8 silencing, as shown in Fig. 4B. 
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Fig. 11. Effect of AQP3 and AQP8 silencing on intracellular ROS level in B1647 cells. 
(A) 24 h after transfection with siRNA, cells were treated with 100 µM H2O2, then intracellular ROS level was 
evaluated as DCF fluorescence as described in Materials and Methods. Data are expressed as % of control and represent 
means ± SD of, at least, three independent experiments. Data were analysed by one-way ANOVA followed by 
Bonferroni's test: *p < 0.05 significantly different from control; §p < 0.05 significantly different from cells treated with 
100 µM H2O2. (B) 24 h after transfection with siRNA, cells were treated with 10 µM DPI, then intracellular ROS level 
was evaluated as DCF fluorescence. Data are expressed as % of control and represent means ± SD of, at least, three 
independent experiments. Data were analysed by one-way ANOVA followed by Bonferroni's test: *p < 0.05 
significantly different from control; §p < 0.05 significantly different from cells treated with 10 µM DPI. 
 
From the comparison of Figs. 1B and 2A with Figs. 4A and 4B, it can be seen that the inhibition 
profile of ROS formation obtained by the use of AQP and Nox inhibitors or by AQP silencing are 
similar. From the data obtained by the silencing technique it was possible to observe that AQP8 
isoform, rather than AQP3, is able to transport H2O2 through the plasma membrane of B1647 cell 
line. 
 
4.1.4 Evaluation of the effect exerted by AQP overexpression on intracellular ROS level 
As well as the inhibition of an enzyme activity could be helpful in the understanding of its 
involvement in a biological process, the overexpression of its level amplifies its effect, 
corroborating the evidence obtained. Furthermore, overexpressed levels of AQPs in vivo are used as 
marker for several cancer types, thus this technique can mimic a pathological condition.  
B1647 cells were transfected by electroporation with different plasmids designed for the 
overexpression of AQP1, AQP3 or AQP8, and in this case the overexpression of AQP1 was 
considered as a positive control. The transfection efficiency was estimated as fluorescent/non-
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fluorescent cell ratio 24 hours after the electroporation with a GFP vector (see Materials and 
Methods section), and resulted to be about 70%.  
Fig. 5A shows the Western blotting analysis of the target isoforms overexpression compared to their 
constitutive expression.  
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Fig. 12. AQP1, AQP3 and AQP8 overexpression and its effect on cell viability/proliferation in B1647 cells. 
(A) B1647 cells were transfected by electroporation with plasmids designed for the overexpression of AQP1, AQP3, 
AQP8 or electroporated without DNA and lysed after 24 h. Overexpression of target isoforms was confirmed by 
Western blot with specific antibodies against AQP1, AQP3 or AQP8. The images show a representative experiment out 
of three independent analyses. 
(B) B1647 cells were transfected by electroporation with plasmids designed for the overexpression of AQP1, AQP3, 
AQP8 or electroporated without DNA. After 24 h the cells were lysed, then viability/proliferation were evaluated by 
MTT assay as described in Materials and Methods, and compared to Control. Data are expressed as % of control and 
represent means ± SD of, at least, three independent experiments. Data were analysed by one-way ANOVA followed by 
Bonferroni’s test. No significant differences were revealed. 
 
Densitometric analysis normalized by actin content shows that AQP3 overexpression causes a 3.5-
fold protein increase and AQP8 overexpression produces a 4.1-fold protein increase. 
Trypan blue exclusion test (not shown) and MTT assay were performed 24 and 48 hours (not 
shown) after transfection, and data reported in Fig. 5B showed no significant differences in the 
viability of the cells transfected with the three plasmidic vectors compared to the control cells 
electroporated without DNA. 
Twenty-four hours after transfection, intracellular ROS level was measured by means of DCF 
fluorescence either in basal condition or after 100 µM H2O2 addition. 
As it can be seen in Fig.6A only AQP8 overexpression caused a little but significant increase in 
ROS basal level, while all of the three overexpressed isoforms were able to significantly enhance 
the intracellular ROS level in the presence of H2O2 (Fig. 6B).  
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Fig. 13. Effect of AQP overexpression on intracellular ROS level in B1647 cells.  
B1647 cells were transfected by electroporation with plasmids designed for the overexpression of AQP1, AQP3, AQP8 
or electroporated without DNA. (A) 24 h after transfection, the intracellular ROS level of cells overexpressing different 
AQP isoforms was evaluated as DCF fluorescence as reported in Material and Methods. Data are expressed as % of 
control and represent means ± SD of three independent experiments. Data were analysed by one-way ANOVA followed 
by Bonferroni's test: *p < 0.05 significantly different from control. (B) 24 h after transfection, cells overexpressing 
different AQP isoforms were treated with 100 µM H2O2, then intracellular ROS level was evaluated as DCF 
fluorescence. Data are expressed as % of control and represent means ± SD of at least three independent experiments. 
Data were analysed by one-way ANOVA followed by Bonferroni's test: *p < 0.05 significantly different from control. 
 
These results, along with that obtained in AQP3 and AQP8 silencing conditions, strongly support 
the notion that AQP8 and, in a lesser extent, AQP3 are able to funnel H2O2 across the plasma 
membrane in the acute leukemia B1647 cell line. 
 
4.1.5 Effect of AQP isoforms on VEGF-dependent modulation of ROS intracellular level 
The angiogenic growth factor VEGF exerts proliferative and migratory effects on endothelium, thus 
tyrosine kinase receptor VEGF receptor 2 (VEGFR-2) was thought to be exclusively expressed by 
adult endothelial cells. Since endothelial and hematopoietic cells share a common progenitor, 
known as hemangioblast, it has been shown that VEGF and VEGFR-2 are also expressed in a 
subset of multipotent hematopoietic stem cells (Ziegler, Valtieri et al. 1999) and in many leukemia 
cells (Fiedler, Graeven et al. 1997). 
Therefore, coinciding expression of VEGF/VEGF receptors may result in the generation of an 
autocrine loop supporting the proliferation and survival of leukemia cells. 
It has been shown that B1647 cells constitutively produces VEGF and express its VEGFR-2 
receptor (Bonsi, Pierdomenico et al. 2005), thus VEGF/VEGFR-2 signalling pathway ensures the 
viability and the fast proliferation of these cells. In particular, the research group demonstrated that 
Nox-derived ROS provoke VEGFR-2 autophosphorylation, which causes the modulation of many 
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cellular activities, among which glucose uptake, strictly bound to VEGF-induced leukemic cell 
survival and proliferation (Maraldi, Prata et al. 2010). 
Therefore, since it has been demonstrated that AQP isoforms mediate H2O2 transfer across the 
plasma membrane in B1647 cells, changes in AQP activity could be linked to VEGF signal 
proceeding through Nox proteins, thereby modulating the intracellular ROS level. In order to test 
this hypothesis, overexpressing and silenced AQPs cells were exposed to exogenous VEGF and 
assayed for intracellular ROS production. 
To better evaluate the VEGF role, keeping out the effect of other growth factors, AQP1, AQP3 or 
AQP8 overexpressing cells and AQP3 or AQP8 silenced cells were serum starved for 16 hours. 
Cells were then stimulated with 50 ng/mL exogenous VEGF for 30 min and assayed for 
intracellular ROS level, as reported in Fig. 7. 
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Fig. 14. Effect of VEGF on intracellular ROS level of AQP overexpressing or AQP silencing B1647 cells.  
(A) B1647 cells were transfected by electroporation with plasmids designed for the overexpression of AQP1, AQP3, 
AQP8 or electroporated without DNA. After 24 h from transfection, control and overexpressing AQP1, AQP3 or AQP8 
cells were serum starved for 16 h and then stimulated for 30 min with 50 ng/mL VEGF. The intracellular ROS level 
was evaluated as DCF fluorescence as reported in Material and Methods. Data are expressed as % of control and 
represent means ± SD of at least three independent experiments. Data were analysed by one-way ANOVA followed by 
Bonferroni's test: *p < 0.05 significantly different from corresponding VEGF untreated cells; §p < 0.05 significantly 
different from VEGF treated control cells. (B) cells were transfected by electroporation with specific siRNA against 
AQP3, AQP8 or a random RNA sequence (scrambled) as control. After 24 h from transfection, control, AQP3 or AQP8 
silenced cells were serum starved for 16 h and then stimulated for 30 min with 50 ng/mL VEGF. Then, intracellular 
ROS level was evaluated as DCF fluorescence. Data are expressed as % of control and represent means ± SD of at least 
three independent experiments. Data were analysed by one-way ANOVA followed by Bonferroni's test: *p < 0.05 
significantly different from corresponding VEGF untreated cells; §p < 0.05 significantly different from control cells. 
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Treatment with exogenous VEGF caused an increase in intracellular ROS level at the same extent 
in control, AQP1 and AQP3 overexpressing cells, while the VEGF-induced ROS increase in AQP8 
overexpressing cells was significantly higher (Fig. 7A). 
As it can be seen in Fig. 7B, VEGF-stimulated ROS production was not affected in AQP3 silenced 
cells, while the intracellular ROS content decreased significantly in AQP8 silenced cells, both in 
control and VEGF-treated cells.  
These data confirm the above hypothesis and corroborate the importance of AQP8 constitutive 
expression in modulating VEGF-induced ROS generation.  
 
4.2 Redox Signalling in Human Leukaemia Cells: Role of VEGF/VEGFR 
In recent studies, the expression of VEGF/VEGFR in acute myeloid leukaemia patients has been 
detected and the increased level of plasma VEGF has been correlated with reduced survival 
(Aguayo, Kantarjian et al. 2002). Moreover, leukaemia cells have been associated with 
angiogenesis, upon the demonstration that leukaemia progression is accompanied by an increase in 
bone marrow vascularization (Perez-Atayde, Sallan et al. 1997). Therefore, the elucidation of the 
mechanism underlying VEGF/VEGFR activity in leukaemia cells is necessary for the development 
of new therapeutic agents. 
Caveolae and lipid rafts are ordered structures of membrane microdomains, characterized by high 
concentration of cholesterol and glycosphingolipids, which are involved in fundamental cellular 
functions such as endocytosis, protein trafficking and signal transduction (Patel and Insel 2009). In 
endothelial cells, VEGFR-2 is present in caveolae through association with Caveolin-1 (Cav-1), 
which negatively regulates the receptor activity in basal state. Dissociation of VEGFR-2 from 
caveolae/Cav-1 seems to be essential for VEGFR-2 autophosphorylation and activation of 
downstream signalling events (Labrecque, Royal et al. 2003). Recent experimental evidence shows 
that, in endothelial cells, VEGF promotes the release of VEGFR-2 from caveolae/lipid rafts, thereby 
inducing its activation (Ushio-Fukai 2007). With the present experiments, the potential involvement 
of plasma membrane caveolae/lipid rafts in VEGF-mediated redox signaling was investigated in the 
human leukaemia B1647 cell line. 
 
4.2.1 Effect of methyl-β-cyclodextrin on plasma membrane cholesterol depletion 
The maintenance of cholesterol levels is essential for functional caveolae and depends, in part, on 
the interaction of cholesterol with Cav-1, the major structural component of caveolae (Labrecque, 
Royal et al. 2003). As well as the use of inhibitors is helpful in understanding the biological role of 
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a protein, disassembling of caveolae/lipid rafts can be useful to clarify the functions they are 
involved in. 
It has been shown that cyclodextrins remove cholesterol from cultured cells (Ohtani, Irie et al. 
1989; Kilsdonk, Yancey et al. 1995; Klein, Gimpl et al. 1995), since they are cyclic glucose 
oligomers able to sequester lipophilic molecules in their hydrophobic core (Pitha, Irie et al. 1988). 
Among the different cyclodextrin derivatives, methyl-β-cyclodextrin was shown to be the most 
efficient as acceptor of cellular cholesterol, and the most commonly used (Klein, Gimpl et al. 1995; 
Zidovetzki and Levitan 2007). Therefore, methyl-β-cyclodextrin (CD) was chosen in the subsequent 
experiments to induce cholesterol depletion from plasma membrane of B1647 cell line, thereby 
disrupting caveolae/lipid rafts. 
First of all, experiments were performed to set the desired conditions, as the degree of cholesterol 
depletion is a function of the CD concentration, incubation time, temperature and cell type 
subjected to the treatment (Christian, Haynes et al. 1997). The purpose was to achieve a lipid 
environment alteration associated with membrane integrity and viable cells. 
B1647 cells suspended in culture medium were incubated overnight with [3H]-cholesterol (0.5 
mCi/mL), then washed and exposed to different CD concentrations (2.5-25 mM) for 20-40 min in 
order to find the best working conditions (not shown). 
Fig. 8A shows the time course of CD effect on cholesterol level, evidencing that cell treatment with 
5 mM CD for 20 min was able to remove about 60% cholesterol. In these conditions cell viability 
was affected only about 10%, as resulted by Trypan Blue exclusion test (Fig. 8B) and MTT assay 
(not shown). Higher CD concentrations caused an higher decrease in cell viability, therefore 5 mM 
CD for 20 min was the treatment selected for the following experiments. 
 
Fig. 15. Effect of CD concentration and incubation time on cholesterol content and cell viability in B1647 cells. 
(A) B1647 cells were incubated with [3H]-cholesterol (0.5 µCi/mL) in cell culture medium for 16 h at 37 °C, washed, 
re-suspended in PBS and treated with 5 mM CD for different time periods (0-30 min). Cell suspensions were washed 
with PBS, then [3H]-cholesterol content was estimated by liquid scintillation counting. (B) The viability of the cells 
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treated with different CD concentrations (5-10 mM) for 20 min was evaluated by Trypan Blue exclusion test as 
described in the Materials and Methods. Data are expressed as % of control and represent means ± SD of three 
independent experiments, each performed in triplicate. Data were analysed by one-way ANOVA followed by 
Bonferroni’s test :**p < 0.005, significantly different from control cells; ***p < 0.0005, significantly different from 
control cells. 
 
4.2.2 Isolation and identification of membrane caveolae/lipid rafts by detergent extraction and 
sucrose gradient centrifugation in B1647 cells 
The isolation and identification of membrane caveolae/lipid rafts from the other portions of B1647 
plasma membranes is the first step requested to investigate VEGFR-2 localization in this cell type. 
Historically, caveolae/lipid rafts have been defined functionally by their low density and 
insolubility in cold 1% Triton X-100, thereby forming the Detergent Resistant Membrane fraction 
(DRM), and other membrane fractions that are solubilised by TX-100. Then caveolae/lipid rafts are 
isolated by flotation in a linear sucrose density gradient, where they distribute in the top few 
fractions of the gradient. This procedure yields a fairly consistent product that is enriched in 
cholesterol and raft marker proteins (L. J. Pike Journal of Lipid Research vol. 44, pp. 655-667, 
2003). 
B1647 cells were lysed using TX-100, centrifuged and the supernatant was collected and 
subsequently subjected to sucrose density-gradient (5-40%) centrifugation as described in the 
Materials and Methods section and the results are shown in Fig. 9A. Nine fractions were collected 
and analysed by SDS-PAGE followed by Western blotting using anti-flotillin-2 (48 kDa), anti-
caveolin-1 (24 kDa) and anti-Lyn (58 kDa) antibodies as protein markers for DRM fractions. 
Indeed, flotillin-2 and Lyn are known to be associated with caveolae/lipid rafts in different cell lines 
(Barnes, Ingram et al. 2004), as well as Cav-1. The transferrin receptor (CD71), an integral 
membrane protein, was selected as a marker for detergent-soluble non-raft membrane fractions.  
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Fig. 16. Isolation and identification of membrane caveolae/lipid rafts by detergent extraction and sucrose 
gradient centrifugation in B1647 cell line.  
(A) Cells were lysed with 1% Triton X-100 at 4 °C and separated by sucrose density-gradient ultracentrifugation as 
described in Materials and Methods. Equal aliquots of each fraction were subjected to SDS-PAGE and Western 
blotting. Flotillin-2, caveolin-1 and Lyn were used as markers for caveolae/lipid raft fractions; CD71 for non lipid raft 
fractions. (B) Typical profile of protein concentrations in gradient fractions after ultracentrifugation. Protein content 
was determined as described in Materials and Methods. Data represent means  ± SD of three independent experiments, 
each performed in triplicate. Data were analysed by one-way ANOVA followed by Bonferroni’s test: °p < 0.01, 
significantly different from each other. 
 
As it can be seen in Fig. 9A, flotillin-2, Lyn and Cav-1 are localized in the low-density region of the 
gradient (fractions 2-6), where caveolae/lipid rafts are supposed to be, instead, CD71 is located in 
the fractions 6-9, corresponding to non-raft membrane fractions localization. 
Fig. 9B shows the protein content of the different gradient fractions. It can be seen that the amount 
of proteins present in the DRM fractions is undetectable with this procedure (although evident in 
the Western blot), and the main part of B1647 proteins was found in the high-density region of the 
sucrose gradient. 
 
4.2.3 Effect of cholesterol depletion on VEGFR-2 localization in B1647 cells 
In order to investigate the effect of disrupting caveolae/lipid rafts on VEGFR-2 localization, B1647 
cells, deprived or not of human serum (HS), were subjected to 5 mM CD treatment for 20 min, 
lysed by using TX-100, and separated by sucrose density-gradient centrifugation as previously 
described. 
Also in this case nine fractions were collected and analysed by SDS-PAGE followed by Western 
blotting using anti-VEGFR-2 antibody, in order to observe VEGFR-2 localization.  
As reported in Fig. 10, VEGFR-2 distribution differs between serum-starved (- HS) or serum added 
(+ HS) cells. In serum starved cells VEGFR-2 is present both in raft and non raft regions, whereas 
in serum added cells VEGFR-2 content increases in the non-raft fractions, suggesting that VEGF is 
able to link to its receptor causing a shift of the VEGF/VEGFR-2 complex towards non-caveolar 
membrane regions. 
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Fig. 17. Effect of methyl-β-cyclodextrin on VEGFR-2 localization in B1647 cells.  
B1647 cells in the presence or absence of human serum (HS) pre-treated or not with 5 mM CD for 20 min were lysed 
with 1% Triton X-100 at 4 °C and separated by sucrose density-gradient ultracentrifugation as described in the 
Materials and Methods. Equal aliquots of each fraction were subjected to SDS-PAGE, Western blotting and revealed 
for anti-VEGFR-2 (210 kDa). A representative blot is shown. 
 
It can be seen also that cell treatment with CD resulted in the redistribution of VEGFR-2 from 
caveolae/lipid rafts to non-caveolar fractions both in the presence and in the absence of HS, owing 
to the caveolae/lipid raft disruption.  
Since it has been shown that CD is capable of removing cholesterol from both raft and non raft 
fractions (Gaus, Chklovskaia et al. 2005), experiments were performed to ensure that the efficiency 
of cholesterol removal was higher in DRM fractions The results (not shown) confirmed that 
fractions 2-6, corresponding to caveolae/lipid rafts in our experimental conditions, exhibited the 
higher cholesterol depletion compared to other fractions.  
These data demonstrated that, as well as in endothelial cells, also in a human leukemia cell line 
VEGFR-2 is partially localized in caveolae/lipid rafts and that the VEGF/VEGFR-2 interaction 
displaces the receptor from raft to non raft regions.  
 
4.2.4 Effect of cholesterol depletion from plasma membrane on ROS generation and glucose 
transport activity in B1647 cells 
Since it has been demonstrated that CD treatment provokes a partial movement of VEGFR-2 from 
caveolae/lipid rafts towards non-caveolar membrane regions, it is interesting to investigate whether 
this receptor redistribution could correspond to its activation.  
Therefore, experiments were performed in order to examine the effect of CD (in the presence or 
absence of HS) on intracellular ROS level and glucose uptake, two downstream events linked to 
VEGF/VEGFR-2 signaling pathway.  
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Figs. 11A and B show that, when HS is present, the CD effect is negligible on both ROS production 
(Fig. 11A) and glucose uptake (Fig. 11B), since in this condition VEGF-VEGFR-2 pathway is 
partially already activated. On the other hand, when cells were serum starved, CD treatment 
significantly enhanced both parameters, probably because VEGF-VEGFR-2 interaction is facilitated 
by the partial caveolae/lipid raft disruption, thereby triggering the signal transduction pathway 
which leads to an increased ROS generation and glucose uptake. 
Moreover, analyses of the images obtained by immunofluorescence microscopy of cells labelled 
with an anti-Glut1 antibody against an extracellular domain of Glut1 revealed that incubation with 
CD, in condition of serum starvation, greatly enhances the staining for the transporter at the cell 
surface (Fig. 11C). These results indicate that CD treatment increases glucose uptake through Glut1 
recruitment into the plasma membrane from intracellular pool. 
 
 
Fig. 18. Effect of methyl-β-cyclodextrin on ROS generation, glucose transport activity and Glut1 translocation in 
B1647 cells.  
(A) B1647 cells in the presence or absence of human serum (± HS) and pretreated or not with 5 mM CD for 20 min (± 
CD) were incubated with 5µM DCFH-DA, then ROS intracellular level was measured spectrofluorimetrically as 
described in the Materials and Methods. (B) Cells in the presence or absence of human serum (± HS) and pretreated or 
not with 5 mM CD for 20 min (± CD) were incubated with DOG mixture, then glucose uptake was assayed by liquid 
scintillation counting as described in the Materials and Methods. Data in panel A and B are expressed as % of control 
and represent means  ± SD of three independent experiments. Data were analysed by one-way ANOVA followed by 
Bonferroni’s test: ***p < 0.001, significantly different from control cells (+ HS, - CD). (C) Cells in the presence or 
absence of human serum (± HS) and incubated (or not) in PBS at 37 °C with 5 mM CD for 20 min (± CD) were fixed in 
3% (w/v) paraformaldheyde for 15 min. Cells were then immunolabelled with anti-Glut1 (N-20) antibody (raised 
against an extracellular domain of Glut1, therefore evidencing Glut1 present on the cell surface), treated with 
fluorescent FITC-conjugated secondary antibody and visualized using immunofluorescence microscopy.  
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These results confirm that the disrupting effect caused by CD on B1647 plasma membrane 
caveolae/lipid rafts leads to VEGFR-2 redistribution to a non caveolar region, implying its 
consequent activation. 
 
4.2.5 The relationship between VEGFR-2 and Caveolin-1 
As previously stated, an association between VEGFR-2 and Cav-1 has been reported in endothelial 
cells, which negatively regulates the receptor activity in basal state. To investigate whether an 
interaction/co-localization between VEGFR-2 and Cav-1 also exists in B1647 cells and, if so, 
whether this relationship could affect the VEGFR-2 activation, the following immunoprecipitation 
experiments were performed. 
B1647 cells were serum starved or not for 18h, then immunoprecipitated for anti-VEGFR-2. The 
samples were then subjected to SDS-PAGE and Western blotting analysis, using anti-Cav-1 and 
anti-phospho-tyrosine antibodies.  
As reported in Fig. 12, in serum starved condition (- HS) Cav-1 and VEGFR-2 colocalize, and 
VEGFR-2 is slightly phosphorylated. On the other hand, when serum is present, the association 
between VEGFR-2 and Cav-1 is significantly less evident, whereas VEGFR-2 phosphorylation is 
markedly increased. These results are in accordance with those obtained in endothelial cells, where 
Cav-1 acts as negative regulator of VEGFR-2 activity, as previously stated.  
 
 
 
Fig. 19. Association of VEGFR-2 with Caveolin-1 in B1647 cells.  
Cells deprived or not of serum (± HS) were subjected to immunoprecipitation with anti-VEGFR-2 as described in 
Materials and Methods. Samples were electrophoresed, immunoblotted and revealed for anti-Cav-1, anti-phospho-
tyrosine or with anti-VEGFR-2 as control. A representative blot is shown. Results were obtained considering three 
independent Western blot experiments. Relative amounts were determined by scanning densitometry and are expressed 
in arbitrary units. *p < 0.05, significantly different from control cells (+ HS). 
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4.2.6 The modulation of the VEGF/VEGFR-2 interaction on ROS intracellular level and glucose 
uptake 
As above stated, the elucidation of the mechanism underlying VEGF/VEGFR activity in leukemia 
cells could be very useful for the development of new therapeutic strategies and agents. 
To this purpose, the effect of different compounds able to inhibit VEGF/VEGFR-2 interaction by 
different mechanisms was investigated in B1647 cell line. 
Bevacizumab was selected as a monoclonal antibody against VEGF since this drug is the most 
commonly used against VEGF-sustained cancers (Yang, Zhang et al. 2013). Semaxinib was chosen 
for its ability to inhibit VEGFR-2 tyrosine kinase activity, although the evaluation of its effect on 
ROS intracellular level is prevented by its autofluorescence (Vajkoczy, Menger et al. 1999). 
Finally, to deeply investigate the role of Cav-1 in B1647 cell model, the Cav-1 scaffolding domain 
(CSD), representing the portion of the protein (residues 82 to 101) essential for Cav-1 interaction 
with other proteins (Couet, Li et al. 1997), was used.  
First of all, the influence of these compounds on B1647 cell viability was evaluated and the results 
were reported in Fig. 13. It can be seen that the three treatments, protracted until 2 hours, did not 
affect B1647 cell viability. 
 
Fig. 20. Effect of Bevacizumab, Semaxinib or CSD on B1647 cell viability. 
B1647 cells were incubated for 2 hours with 3.4 nM Bevacizumab, or 20 µM Semaxinib, or 5 µM CDS. 
Viability/proliferation was evaluated by MTT assay as described in Materials and Methods, and compared to control. 
Results are expressed as means  ± SD of three independent experiments. Data were analysed by one-way ANOVA 
followed by Bonferroni’s test. No significant differences were revealed. 
 
Subsequently, B1647 cells in the presence or absence of human serum (± HS), were assayed for 
ROS intracellular level after pre-treatment with Bevacizumab (30 min) and CSD (2h) and the 
results are shown in Fig. 14A. In agreement with previous data, it can be seen that, in serum 
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cultured cells, the VEGF treatment is unable to induce ROS generation, since in this basal condition 
VEGF/VEGFR-2 signalling pathway is already activated, on the contrary 50 ng/mL VEGF 
treatment in serum-starved cells caused a significant increase in ROS level, reaching about the same 
ROS content of control cells. As far as the treatment with Bevacizumab or CSD is concerned, it can 
be seen that it was able to cause a significant decrease of intracellular ROS level independently on 
the presence of HS or VEGF. 
Cells subjected to the same treatments and incubated with the different inhibitors were analysed for 
glucose transport (Fig. 14B), obtaining results very similar to that reported in Fig. 14A. 
 
Co
ntr
ol
Ve
gf
Be
va
ciz
um
ab
Be
va
ciz
um
ab
+V
eg
f
CS
D
CS
D+
Ve
gf
Co
ntr
ol 
de
p 
Ve
gf
Be
va
ciz
um
ab
Be
va
ciz
um
ab
+V
eg
f
CS
D
CS
D+
Ve
gf
0
50
100
150
-HS
* * *
* § § § §
§
A
DC
F 
flu
o
re
sc
en
ce
 
(%
)
 
Co
ntr
ol
Ve
gf
Se
m
ax
ini
b
Se
m
ax
ini
b+
Ve
gf
Be
va
ciz
um
ab
Be
va
ciz
um
ab
+V
eg
f
CS
D
CS
D+
Ve
gf
Co
ntr
ol 
de
p 
Ve
gf
Se
m
ax
ini
b
Se
m
ax
ini
b+
Ve
gf
Be
va
ciz
um
ab
Be
va
ciz
um
ab
+V
eg
f
CS
D
CS
D+
Ve
gf
0
50
100
150
-HS
*
*
* *
* *
§
§
§
§
§
§
§
B
G
lu
co
se
 
Tr
an
sp
o
rt
 
(%
)
 
Fig. 21. Effect of different inhibitors of VEGF/VEGFR-2 interaction on intracellular ROS level and glucose 
uptake in B1647 cells.  
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(A) B1647 cells, control and serum-starved (-HS, “Control dep”) were treated with 500 µg/mL Bevacizumab (3.4 nM) 
for 30 min or 5 µM Cav-1 Scaffolding Domain (CSD) for 2h, in the presence or absence of 50 ng/mL VEGF; then the 
intracellular ROS level was spectrofluorimetrically measured by means of DCFH-DA, as described in Materials and 
Methods. Data are expressed as % of control and represent means ± SD of three independent experiments. Data were 
analysed by one-way ANOVA followed by Bonferroni’s test: *p < 0.05, significantly different from control cells; §p < 
0.05, significantly different from serum deprived control cells (- HS, Control dep). 
(B) B1647 cells, control and serum-starved (- HS, “Control dep”) were treated with 20 µM Semaxinib for 2 h, or 500 
µg/mL Bevacizumab (3.4 nM) for 30 min or 5 µM Cav-1 Scaffolding Domain (CSD) for 2h, in the presence or absence 
of 50 ng/mL VEGF; then glucose uptake was assayed by liquid scintillation counting as described in Materials and 
Methods. Data are expressed as % of control and represent means ± SD of three independent experiments. Data were 
analysed by one-way ANOVA followed by Bonferroni’s test: *p < 0.05, significantly different from control cells; §p < 
0.05, significantly different from serum deprived control cells (- HS, Control dep).  
 
The results obtained with the three compounds able to inhibit VEGF/VEGFR-2 interaction confirm 
the importance of this molecular complex in maintaining the redox loop leading to high intracellular 
ROS level and glucose uptake in B1647 cells. 
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4.3 The maintenance of ROS balance inside the cells: Role of natural or 
physiological molecules  
When ROS formation is dysregulated and goes beyond antioxidant defences, oxidative stress takes 
place, and when oxidative stress exceeds the ability of cell to repair biomolecule oxidation, 
oxidative damage occurs. During oxidative stress, the resulting cellular response is likely to involve 
both redox signalling and oxidative damages, whose contribution will depend on the concentration 
and nature of the ROS involved. When a redox imbalance occurs, a variety of cellular responses is 
activated, in order to minimize the potential damages and to re-establish the correct redox 
homeostasis. 
The role of natural or physiological molecules in maintaining or altering the ROS balance inside the 
cells is, therefore, of extreme interest and intensively explored. Recent epidemiological studies 
demonstrated that increased consumption of cruciferous vegetables rich in organosulfur compounds 
is associated with reduced incidence of human cancer as well as atherosclerotic coronary heart 
diseases, inflammatory and oxidative stress-related disorders (Xue, Qian et al. 2008).  
Sulforaphane (SF) [1-isothiocyanate-(4R)-(methylsulfinyl) butane] is one of the most abundant 
molecule found in these vegetables, and its chemopreventive role has been demonstrated in many 
cellular or animal models (Shapiro, Fahey et al. 2001). In particular, its mechanism seems to rely on 
the induction of phase II enzymes and antioxidants in cell lines and in animals (Fahey and Talalay 
1999), as demonstrated also in cardiomyocytes by our group (Angeloni, Leoncini et al. 2009).  
Cellular redox response mechanism is realized also by the transcription of a variety of antioxidant 
genes through sequences known as antioxidant response elements (ARE). The relationship between 
oxidative stress, activation of these ARE sequences and subsequent gene transcription is often 
mediated by specific transcription factors, such as the Nrf2 (nuclear factor erythroid 2-related factor 
2), which plays a key role in a number of physiological and disease processes (Chen and Kong 
2004). In response to oxidative stress, Nrf2 up-regulates phase II gene products aimed at 
detoxification, cytoprotection, and clearance of potential carcinogens as well as at the reduction of 
excessive ROS accumulation (Wilson, Kerns et al. 2013). 
Among the many genes and gene products up-regulated by Nrf2 there are heme oxygenase 1 (HO-
1), a protein having antioxidant, anti-inflammatory and antiapoptotic activity, or peroxiredoxin-1, 
(Prx-1), which is essential for eliminating H2O2 generated by a variety of cellular stresses and pro-
inflammatory cytokines and has a protective role against oxidative stress-induced apoptosis. 
In recent years, another protein, whose name is Klotho, has gained a great attention. Discovered in 
1997, the Klotho gene has immediately attracted increasing interest, since its overexpression in 
small animals extends lifespan, whereas defective Klotho expression results in rapid aging and 
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early death. It seems that the same pathways might work in humans. The Klotho protein exists in 
two forms: membrane Klotho, which functions as a receptor, and secreted Klotho, which functions 
as a humoral factor with an enzymatic activity (Kuro-o 2011). Both the Klotho forms have 
regulatory effects on general metabolism.  
Part of the experiments concerning the study of the role of natural and physiological molecules in 
the maintenance of redox balance was performed at the King's College London (Cardiovascular 
Division, School of Medicine) under the supervision of Dr. Richard Siow and Dr. Giovanni Mann. 
Dr. Mann’s team is interested in the role of antioxidant genes in vascular protection. Therefore, in 
his lab it has been studied the effect of a variety of molecules able to modulate the expression of 
antioxidant genes thus contributing to the protection of vascular dysfunction in atherosclerosis, 
diabetes and hypoxia condition. Among these natural molecules, the role of sulforaphane in 
mediating the pre-activation of Nrf2 and its downstream target HO-1 in the cerebral vasculature was 
studied by Dr. Mann’s group (Alfieri, Srivastava et al. 2013). 
For these reasons, the effects of sulforaphane (SF) or Klotho (Kl) on HO-1 and Prx-1 expression 
and GSH intracellular level were studied in cultured human aortic smooth muscle cells (HASMC) 
subjected to high glucose conditions mimicking hyperglycaemia. In fact, it has been shown that 
several pathologies such as dislipidaemia, hypertension, diabetes and metabolic syndrome can 
induce an increased oxidative stress, leading to cardiovascular disease or increased risk factors 
(Hopps, Noto et al. 2010).  
 
4.3.1 Effect of sulforaphane on HO-1 and Prx-1 expression in HASMC 
As far as SF toxicity is concerned, it has been shown that the consumption of broccoli and other 
cruciferous vegetables produces SF plasma concentrations ranging between 0.031-7.3 µM, reaching 
a maximum at 1.5-2h (Dinkova-Kostova & Kostov, 2012). These concentrations guarantee safety 
and efficacy of SF (Dinkova-Kostova & Kostov, 2012). For this reason the non toxic concentrations 
of 2.5 µM and 5 µM SF were chosen for the following experiments.  
All the experiments were performed in HASMC maintained in three different conditions for 24 
hours: 
- “Normal Glucose, NG”: 5 mM glucose in the colture medium DMEM; 
- “High Glucose, HG”: 25 mM glucose in the colture medium DMEM, to mimic an hyperglycaemia 
condition; 
- “Mannitol, Man”: 5 mM glucose + 20 mM mannitol in the colture medium DMEM, as osmotic 
positive control with respect to HG. 
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After this period, HASMC were treated with 2.5 µM or 5 µM SF for 12 or 24 hours. The whole 
HASMC lysates were then subjected to SDS-PAGE and Western blotting analysis, using anti-HO-1 
and anti-Prx-1 antibodies and the results are shown in Fig. 15A. Fig. 15B shows that SF treatment 
causes a significant increase in HO-1 expression, which is strongly proportional to SF 
concentration. Also Prx-1 expression is augmented in HASMC following SF treatments, but in this 
case the increase is significant only with 5 µM SF and particularly in mannitol conditions (Fig. 
15C). 
 
     
 
Fig. 22. Effect of 12 hours sulforaphane treatment on HO-1 and Prx-1 induction in HASMC maintained in 
Normal Glucose, High Glucose, or Mannitol conditions. 
(A) Confluent HASMC were maintained in NG, HG and Man for 24 hours in DMEM, then treated with vehicle 
(Control; DMSO, 0.01% v/v) or 2.5 and 5 µM SF for 12 hours. Whole cell lysates were collected, electrophoresed, 
immunoblotted and revealed for anti-HO-1, anti-Prx-1 and anti-α-tubulin as control. A representative blot is shown. (B 
and C) Densitometric analysis of HO-1 and Prx-1 expression relative to α-tubulin in HASMC maintained in NG, HG 
and Man for 24 hours in DMEM, then treated with 2.5 and 5 µM SF for 12 hours. Data are expressed as means of six 
independent experiments and were analysed by one-way ANOVA followed by Bonferroni’s test: **p < 0.05 
significantly different from control NG, ***p < 0.001 significantly different from control NG; ⁰⁰p < 0.01 significantly 
different from control HG, ⁰⁰⁰p < 0.001 significantly different from control HG; ##p < 0.01 significantly different from 
control Man, ###p < 0.001 significantly different from control Man. 
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The same experiment was repeated treating HASMC with 2.5 µM or 5 µM SF for 24 hours and the 
results are shown in Fig. 16. From Figs. 16B and 16C it can be seen that after 24 hours the 
increased expression of both the proteins are less dependent on the SF concentration than data 
obtained after 12 hours, particularly in the case of Prx-1 (Fig. 16C). 
 
 
 
Fig. 23. Effect of 24 hours sulforaphane treatment on HO-1 and Prx-1 induction in HASMC maintained in 
Normal Glucose, High Glucose, or Mannitol conditions. 
 (A) Confluent HASMC were maintained in NG, HG and Man for 24 hours in DMEM, then treated with vehicle 
(Control; DMSO, 0.01% v/v) or 2.5 and 5 µM SF for 24 hours. Whole cell lysates were collected, electrophoresed, 
immunoblotted and revealed for anti-HO-1, anti-Prx-1 and anti-α-tubulin as control. A representative blot is shown. (B 
and C) Densitometric analysis of HO-1 and Prx-1 expression relative to α-tubulin in HASMC maintained in NG, HG 
and Man for 24 hours in DMEM, then treated with 2.5 and 5 µM SF for 24 hours. Data are expressed as means of three 
independent experiments and were analysed by one-way ANOVA followed by Bonferroni’s test: **p < 0.01 
significantly different from control NG, ***p < 0.001 significantly different from control NG; ⁰⁰⁰p < 0.001 
significantly different from control HG; ###p < 0.001 significantly different from control Man.  
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4.3.2 Effect of Klotho on HO-1 and Prx-1 expression in HASMC 
Klotho is a molecule of recent discovering, so the effect of 0.1, 0.5, 1 nM Klotho Human 
Recombinant protein addition on HASMC viability and proliferation was analysed by using the 
xCell System iCELLigence Real-Time Cell Analyzer DP inside a cell culture incubator. This real-
time cell system continuously monitors changes in impedance over time, represented arbitrarily as 
the cell index, as described in the Materials and Methods section. For proliferation assay, 
impedance was collected every 15 minutes up to 24 hours. No changes in vitality/ proliferation 
status of the cells were observed, as reported in Figs. 17A and 17B. 
  
 
Fig. 24. Effect of different Klotho concentrations on HASMC viability/proliferation.  
(A) HASM cells were treated for 24 hours with different concentrations of Kl. Red = control, Blue = 0.1 nM, Purple = 
0.5 nM, Green = 1 nM. Viability/proliferation was evaluated by xCell System iCELLigence Real-Time Cell Analyzer 
DP as described in Materials and Methods. (B) Histogram representation of the results shown in Panel A. Data are 
expressed as % of control and represent means ± SD of three independent experiments. Data were analysed by one-way 
ANOVA followed by Bonferroni’s test: no significant differences were observed. 
 
Confluent HASMC were maintained in the three above described conditions (NG, HG, Man) for 24 
hours. After this period, HASMC were treated with 0.1, 0.5 or 1 nM Klotho for 24 hours. The 
whole HASMC lysates were then subjected to SDS-PAGE and Western blotting analysis, using 
anti-HO-1 and anti-Prx-1 antibodies and the results are shown in Fig. 18A. 
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Fig. 25. Effect of 24 hours Klotho treatment on HO-1 and Prx-1 induction in HASMC maintained in Normal 
Glucose, High Glucose, or Mannitol conditions. 
 (A) Confluent HASMC were maintained in NG, HG and Man for 24 hours in DMEM, then treated with 0.1, 0.5, or 1 
nM Kl for 24h. . Whole cell lysates were collected, electrophoresed, immunoblotted and revealed for anti-HO-1, anti-
Prx-1 and anti-α-tubulin as control. A representative blot is shown. (B and C) Densitometric analysis of HO-1 and Prx-1 
expression relative to α-tubulin in HASMC maintained in NG, HG and Man for 24 hours in DMEM, then treated with 
0.1, 0.5, or 1 nM Kl for 24 hours. Data are expressed as means of three independent experiments and were analysed by 
one-way ANOVA followed by Bonferroni’s test: ***p < 0.001 significantly different from control NG; ⁰⁰p < 0.01 
significantly different from control HG, ⁰⁰⁰p < 0.001 significantly different from control HG; ##p < 0.01 significantly 
different from control Man, ###p < 0.001 significantly different from control Man. 
 
Data showed in Figs. 18B and 18C evidence that HASMC treated with exogenous Kl exhibit a 
strongly, significant increase in HO-1 and Prx-1 expression. Regarding to HO-1 (Fig. 18B), the 
highest increase is observed in NG and HG conditions, particularly corresponding to the lowest Kl 
concentration used. A similar trend is observed also in the case of Prx-1 expression (Fig. 18C). It 
has to be pointed out that the most active 0.1 nM Kl concentration is closer to the physiological 
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concentrations of soluble Klotho levels (Golembiewska, Safranow et al. 2013), confirming that Kl 
takes part on the natural antioxidant defences.  
 
4.3.3 Effect of High Glucose condition on GSH intracellular levels in HASMC 
Glutathione (GSH) is ubiquitously expressed in all cell types and it represents the major non-
enzymatic regulator of intracellular redox homeostasis (Masella, Di Benedetto et al. 2005). Changes 
in endogenous antioxidants such as GSH and antioxidant enzymes may reflect a physiological 
consequence provoked by oxidative stress. It has been shown that long-term exposure of cultured 
mouse endothelial cells to high glucose (28 mM) resulted in impaired GSH synthesis and decreased 
GSH levels (Kline, Bassit et al. 2009). 
Therefore, the GSH intracellular level of HASMC maintained in High Glucose condition was 
compared to that measured in the same cells maintained in Normal Glucose and Mannitol 
conditions. After 48 hours growth, the cells were maintained in High Glucose conditions for 6, 12, 
24 or 48 hours and in NG or Mannitol conditions for 48 hours, then GSH intracellular level was 
determined by using OPA fluorescence as described in Materials and Methods section. The results 
reported in Fig. 19 show that High Glucose condition provoked a significant decrease in the 
intracellular GSH level after 48 hours.  
 
 
 
Fig. 26. Effect of different times of exposure to High Glucose condition on intracellular GSH levels in HASMC. 
Confluent HASMC were maintained in HG for 6, 12, 24 or 48 hours, and in NG or Man for 48 hours. Intracellular GSH 
levels were determined employing O-phthaldialdehyde (OPA) fluorescence as described in Materials and Methods. 
Data are expressed as 100% Control, whose actual GSH concentration is 40-50 nmol/ mg of protein.. Data are 
expressed as means ± S.E.M of three independent experiments and were analysed by one-way ANOVA followed by 
Bonferroni’s test: *p < 0.05 significantly different from control NG. 
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4.3.4 Effect of sulforaphane on GSH intracellular level in HASMC 
Since it has been reported that SF enhances the total GSH levels in SH-SY5Y cells (Tarozzi, 
Morroni et al. 2009), it was investigated whether this molecule could be able to restore the depleted 
GSH level observed in HAMSC maintained in HG condition for 48 hours. 
To this purpose, HASMC maintained in NG, HG or Man conditions for 24 hours in DMEM, were 
treated with 2.5 µM or 5 µM SF for 12 or 24 hours in the same three conditions, then the 
intracellular GSH levels were measured. As it can be seen in Figs. 20 A and 20 B, SF treatment 
provoked a significant increase in HASMC intracellular GSH content in all the condition tested, 
both at 12 and 24 hours. In particular, as reported in Fig. 20B, SF was able to completely restore the 
significant depletion of GSH levels observed after 48 hours exposition to HG condition. 
 
Fig. 27. Effect of different times of exposure to sulforaphane on intracellular GSH levels in HASMC. 
Confluent HASMC were maintained in NG, HG or Man conditions for 24 hours in DMEM, then treated with 2.5 or 
5µM SF for (A) 12 hours, (B) 24 hours. Intracellular GSH levels were determined employing O-phthaldialdehyde 
(OPA) fluorescence as described in Materials and Methods. Data are expressed as means ± S.E.M of three independent 
experiments and were analysed by one-way ANOVA followed by Bonferroni’s test: **p < 0.01 significantly different 
from control NG, ***p < 0.001 significantly different from control NG, °°p < 0.01 significantly different from control 
HG, °°°p < 0.001 significantly different from control HG, ##p < 0.01 significantly different from control Man, ###p < 
0.001 significantly different from control Man; § p < 0.05 significantly different from control NG . 
 
4.3.5 Effect of Klotho on GSH intracellular level in HASMC 
GSH disorder plays a role in many pathological disease states such as ageing, diabetes and several 
chronic liver diseases. In aged mice, GSH levels are decreased (Wang, Liu et al. 2003). Since 
Klotho protein has been correlated to aging processes, it might be a relationship between the 
decrease of GSH levels and Klotho function.  
To explore this possibility in the cellular model under investigation, HASM cells maintained in NG, 
HG or Man conditions for 24 hours in DMEM, were treated with 0.1, 0.5, or 1 nM Klotho for 8 or 
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24 hours in the same three conditions, then assayed for the intracellular GSH levels. Results in Fig. 
21A and 21B show that, when HASMC are treated with Klotho, a significant increase in GSH 
intracellular levels occurs in all the tested conditions, with a little major extent corresponding to 24 
hours Kl exposure (Fig. 21B). 
  
Fig. 28. Effect of different times of exposure to Klotho on intracellular GSH levels in HASMC. 
Confluent HASMC were maintained in NG, HG or Man conditions for 24 hours in DMEM, then treated with 0.1, 0.5 or 
1nM Kl for (A) 8 hours, (B) 24 hours. Intracellular GSH levels were determined employing O-phthaldialdehyde (OPA) 
fluorescence as described in Materials and Methods. Data are expressed as means ± S.E.M of three independent 
experiments and were analysed by one-way ANOVA followed by Bonferroni’s test: *p < 0.05 significantly different 
from control NG, **p < 0.01 significantly different from control NG, °p < 0.05 significantly different from control HG, 
°°p < 0.01 significantly different from control HG, #p < 0.05 significantly different from control Man, ##p < 0.01 
significantly different from control Man. 
 
Also these results confirm that Klotho is involved in the physiological antioxidant defences, 
suggesting that a part of its antioxidant effect could proceed through the modulation of GSH 
intracellular levels. 
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4.4 Study of the antioxidant and anti-hyperglycaemic properties of a natural 
molecule 
Topics that have been carried out at the King's College London and those in which the italian 
research group is interested, gave rise to the third problem studied, concerning the antioxidant and 
anti-hyperglycaemic role of steviol glycosides extracted from the perennial shrub Stevia rebaudiana 
Bertoni. Indeed, it was demonstrated that metabolic syndrome and obesity, which often include 
diabetes, are characterized by an altered oxidative/antioxidant status. In particular, hyperglycemia 
and inflammation, important components of these syndromes, increase the production of ROS, 
resulting in an increased oxidative stress with over-activation of NADPH oxidases (Hopps, Noto et 
al. 2010). 
The plant Stevia rebaudiana Bertoni has been used by the native people of Paraguay and Brazil to 
treat diabetes, moreover, the plant’s leaves give out a distinctly sweet taste, containing no calories, 
and are rich in metabolites such as β-carotene, vitamins, terpenes and flavonoids, which give the 
plant its therapeutic advantages (Mohd-Radzman, Ismail et al.). The zero-calorie properties are very 
beneficial to patients suffering from obesity and diabetes, as it will not elevate their blood glucose 
levels, furthermore, a number of animal studies have demonstrated that, in diabetic rats, steviosides 
exert anti-hyperglycemic and insulinotropic actions (Jeppesen, Gregersen et al. 2002).  
Rebaudioside A and stevioside (the two main steviol glycosides found in this plant) are the two 
predominant derivatives used in high potency sweeteners alternative to sucrose, thus the antioxidant 
activity of Rebaudioside A and other commercial Stevia extracts was investigated. Furthermore, as 
above stated, the research group has been studied for a long time the role of glucose transport 
activity in leukaemia cell proliferation, thus, taking advantage from this expertise, the potential 
insulin-like properties of these steviosides were also studied.  
The study was carried out in the neuroblastoma SH-SY5Y and the promyelocytic leukaemia HL-60 
cell lines, since they both express the Glut1 isoform of glucose transporter, which is responsible for 
the basal glucose uptake, and Glut4, responsible for insulin-stimulated glucose uptake in peripheral 
tissues (Lord, Bunce et al. 1988; van der Heide, Ramakers et al. 2006). Furthermore, these cells 
express also the insulin-like growth factor-1 receptors (IGF-1) (Saltiel and Kahn 2001), thereby 
being susceptible to insulin action.  
 
4.4.1 Effect of different Stevia extracts on cell viability and caspase-3 activity in SH-SY5Y and 
HL-60 cell lines 
Four different Stevia extracts, differing by the relative content of Rebaudioside A and stevioside, 
were used for the following experiments:  
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R97: contains 97-98% Rebaudioside A 
R60: contains about 60% Rebaudioside A and about 20% stevioside 
SG: contains 50% Rebaudioside A and at least 25% stevioside 
TRU: contains a mixture of steviol glycoside not analytically quantified. 
First of all, the effect of the four Stevia extracts on cell viability was evaluated by MTT assay, as 
reported in Materials and Methods section. SH-SY5Y and HL-60 cells were treated with different 
concentrations of Stevia extracts (0.5-5 mg/mL, corresponding to 0.5-5 mM R97, which can be 
assumed as a pure compound) for 24 hours. Figs. 22A and 22B show that the extracts did not affect 
cell viability/proliferation, confirming that they are not cytotoxic within the concentration range 
tested.  
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Fig. 29. Effect of different Stevia extracts on SH-SY5Y and HL-60 cell viability/proliferation.  
SH-SY5Y (panel A) and HL-60 (panel B) cells were treated for 24 hours with different concentrations of the four 
extracts (0.1 mg/mL to 5  mg/mL). Viability/proliferation was evaluated by MTT assay as described in Materials and 
Methods, and compared to control (C). Results are expressed as means ± SD of three independent experiments (n=8). 
Statistical analysis was performed by Bonferroni’s multiple comparison test following one-way ANOVA. Significant 
differences were not revealed. 
 
Cytotoxicity was also evaluated by measuring the lactate dehydrogenase (LDH) activity, as reported 
in Materials and Methods section, which is an index of cell membrane integrity. As it can be seen in 
Figs. 23A and 23B, after 24 hours treatment with the different Stevia extracts, the LDH activity did 
not change in both cell lines. LDH activity measured in 100 µM H2O2 treated cells for 30 min was 
shown as positive control. 
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Fig. 30. Effect of different Stevia extracts treatment on lactate dehydrogenase (LDH) activity in SH-SY5Y and 
HL-60 cells. 
LDH activity was measured as described in Materials and Methods. SH-SY5Y (panel A) and HL-60 (panel B) cells 
were treated with the four different extracts at 1 mg/mL final concentration for 24 hours, or cells were treated with 100 
µM H2O2 for 30 min as control of LDH activity. Results are expressed as means ± SD of three independent 
experiments, each performed in triplicate. Statistical analysis was performed by Bonferroni’s multiple comparison test 
following one-way ANOVA. *p < 0.05, significantly different from control cells. 
 
In order to evaluate a possible effect on apoptosis, the activity of caspase 3 was measured, as 
reported in Materials and Methods section. Caspases are a family of cysteine proteases with 
aspartate specificity, playing a central role in various apoptotic responses, where they are activated 
in a sequential cascade of cleavages (Alnemri, Livingston et al. 1996). To detect the enzymatic 
activity of caspase 3, the fluorogenic substrate Ac-DEVD-AMC was used, and staurosporine, a well 
known apoptosis inducer, was employed as positive control. Treatments of cells with Stevia extracts 
for 1 or 6 hours (data not shown) or for 24 hours (Figs. 24A and 24B) did not influence caspase 3 
activity, indicating that the steviol glycosides tested did not induce programmed cell death. 
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Fig. 31. Effect of different Stevia extracts treatment on Caspase 3 activity in SH-SY5Y and HL-60 cells. 
Caspase 3 activity in SH-SY5Y (panel A) and HL-60 (panel B) cells was evaluated in the presence of 1 mg/mL steviol 
glycosides incubated for 24 hours. Staurosporine (Stauro, 1 µg/mL for 4 hours) was used as positive control. Caspase 3 
activity was measured spectrofluorimetrically after 24 hours in cell lysates as reported in Materials and Methods. Each 
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column represents the mean ± SD of three independent experiments. Statistical analysis was performed by Bonferroni’s 
multiple comparison test following one-way ANOVA. *p < 0.05, significantly different from control cells. 
 
4.4.2 Effect of different Stevia extracts on ROS intracellular level in SH-SY5Y and HL-60 cell 
lines 
The antioxidant activity of the four commercial Stevia extracts was investigated in SH-SY5Y and 
HL-60 cells by means of DCF fluorescence, as reported in Materials and Methods section. As 
shown in Fig. 25, the compounds did not exhibit any antioxidant activity, since they were neither 
able to decrease basal ROS level at the highest concentration used (Figs. 25A and 25B) nor to 
counteract intracellular ROS raise due to exogenous oxidative stress (100 µM H2O2 for 30 min) 
(Figs. 25C and 25D). This lack of antioxidant activity is in contrast with the data reported by other 
Authors (Shivanna, Naika et al. 2013; Tavarini and Angelini 2013), probably because the 
compounds used in the present study are commercial sweeteners containing 95-98% steviol 
glycosides with no appraisable amounts of polyphenols, naturally present in Stevia leaves, likely 
responsible for Stevia antioxidant activity. 
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Fig. 32. Effect of different Stevia extracts treatment on intracellular ROS levels in SH-SY5Y and HL-60 cells. 
SH-SY5Y (panel A) and HL-60 (panel B) cells were treated for 1 hour with different Stevia extracts (5 mg/mL), then 
basal ROS levels were measured by means of H2DCFDA assay as described in Materials and Methods. Results are 
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expressed as means ± SD of four independent experiments (n=8). Statistical analysis was performed by Bonferroni’s 
multiple comparison test following one-way ANOVA. Significant differences were not revealed. SH-SY5Y (panel C) 
and HL-60 (panel D) cells were pre-incubated for 1 hour with different Stevia extracts (5 mg/mL) then exposed to 
oxidative stress generated by 100 µM H2O2 for 30 min. ROS levels were measured by means of H2DCFDA assay as 
described in Materials and Methods. Results are expressed as means ± SD of four independent experiments (n=8). 
Statistical analysis was performed by Bonferroni’s multiple comparison test following one-way ANOVA. Significant 
differences were not revealed among H2O2 treated cells. 
 
4.4.3 Effect of different Stevia extracts on glucose transport activity in SH-SY5Y and HL-60 cell 
lines 
The effect of the four different Stevia extracts on glucose transport activity was evaluated in HL-60 
and in SH-SY5Y cell lines, and compared to the effect of 100 nM insulin, a concentration value 
often reported in the literature (Udelhoven, Leeser et al. 2010). Figs. 26A and 26B show that all the 
extracts were able to enhance glucose uptake at similar extent after 1-hour incubation in both 
cellular lines.. More interestingly, results reveal that Stevia extracts and insulin behave similarly, 
being Stevia extracts as efficient as insulin in increasing glucose uptake. Moreover, the co-treatment 
with insulin and Stevia extracts causes a rise of glucose transport significantly higher than the 
increase due to insulin alone. 
C
Ins
uli
n
R9
7
R9
7 +
 
I
R6
0
R6
0 +
 
I
SG
SG
 
+ 
I
TR
U
TR
U 
+ 
I
0
100
200
*
*
* *
SH-SY5Y cells
°
°
°
°
A
*
*
*
*
*
G
lu
co
se
 
u
pt
ak
e
 
(%
 
o
f C
o
n
tr
o
l)
C
Ins
uli
n
R9
7
R9
7 +
 
I
R6
0
R6
0 +
 
I
SG
SG
 
+ 
I
TR
U
TR
U 
+ 
I
0
100
200
*
*
* *
*
HL-60 cells
°
°
°
°
B
* *
*
*
G
lu
co
se
 
u
pt
ak
e
 
(%
 
o
f C
o
n
tr
o
l)
 
Fig. 33. Effects of different Stevia extracts and insulin treatment on glucose transport activity in SH-SY5Y and 
HL-60 cells. 
SH-SY5Y (panel A) and HL-60 (panel B) cells were treated with steviol glycosides (1 mg/mL) or with 100 nM insulin 
(I) or with steviol glycosides and insulin simultaneously. Glucose uptake was assayed as described in the Materials and 
Methods. Results are expressed as means ± SD of three independent experiments, each performed in triplicate. 
Statistical analysis was performed by Bonferroni multiple comparison test following one-way ANOVA. *p<0.05, 
significantly different from control cells; °p<0.05 significantly different from the corresponding cells not stimulated 
with insulin. 
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It is well known that insulin induces the translocation of Glut4 from cytosolic storage vesicles to the 
plasma membrane, thereby enhancing the glucose transport activity. The same behaviour has been 
described for Glut1 in acute leukaemia cell lines in response to different stimuli (Maraldi, Fiorentini 
et al. 2004; Maraldi, Prata et al. 2007). Interestingly, it has been recently shown for the first time in 
a neuronal system that in SH-SY5Y cells both Glut1 and Glut4 are translocated to the plasma 
membrane in response to insulin through a phosphatidylinositol 3-kinase (PI3K)–dependent 
mechanism similar to that described in muscle or adipose tissues (Benomar, Naour et al. 2006). 
Therefore, the expression of Glut1 and Glut4 in neuroblastoma and leukaemia cells following 
treatment with insulin or Stevia extracts was assessed by Western blot analysis on cell lysates (as 
reported in Materials and Methods section). Figs. 27A and 27B report representative immunoblots 
for Glut isoforms and the densitometric analysis (Figs. 27C and 27D) in both cell lines. It can be 
seen that the increase in Glut1 and Glut4 content obtained following exposure to Stevia extracts is 
similar to that obtained by insulin stimulation. These results are in accordance with those observed 
in the evaluation of glucose transport activity. 
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Fig. 34. Effects of different Stevia extracts and insulin treatment on Glut1 and Glut4 content in SH-SY5Y and 
HL-60 cells. 
SH-SY5Y and HL-60 cells, treated with insulin or with steviol glycosides, were lysed with CelLytic M as described in 
Materials and Methods. Cell lysates were electrophoresed and immunoblotted with anti-Glut1 and anti-Glut4 
antibodies, as described in Materials and Methods. β-Actin detection was used as control. Immunoblots representative 
of three independent experiments are reported for SH-SY5Y (A) and HL-60 (B) cell lines. Densitometric analysis 
C D 
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(normalized for β-actin content and expressed as fold of control) is shown for Glut1 (C) and Glut4 (D). Statistical 
analysis was performed by Bonferroni’s multiple comparison test following one-way ANOVA. *p < 0.05, significantly 
different from control cells. 
 
4.4.4 Effect of different Stevia extracts and insulin on PI3K pathway in SH-SY5Y and HL-60 cell 
lines 
It is well known that insulin, through its receptor stimulation, provokes the phosphorylation of 
tyrosine receptor kinases and the activation of a signal transduction pathway involving PI3K and 
Akt (Hers 2007). Since the results thus far obtained show that the Stevia extracts mimic the insulin 
action, the possible involvement of the PI3K signaling pathway in the steviol glycoside action was 
investigated. Then the phosphorylation status of PI3K and Akt was evaluated following Stevia 
extract treatment and insulin stimulation of SH-SY5Y and HL-60 cell lines. Immunoblotting results 
reported in Figs. 28A and 28B and densitometric analysis reported in Figs. 28C and 28D show that, 
upon the treatment with insulin or Stevia extracts, the phosphorylated forms of both PI3K and Akt 
were significantly increased, indicating a possible similar mechanism of action or, at least, a 
common signalling pathway between these two stimuli. 
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Fig. 35. Effects of different Stevia extracts and insulin treatment on PI3K/Akt pathway.  
SH-SY5Y and HL-60 cells, treated with insulin or with steviol glycosides, were lysed with CelLytic M as described in 
Materials and Methods. Cell lysates were electrophoresed and immunoblotted with anti-PI3K, anti-Akt and anti-
phospho-PI3k and anti-phospho-Akt, as described in Materials and Methods. β-Actin detection was used as control. 
Immunoblots representative of three independent experiments are reported for SH-SY5Y (A) and HL-60 (B) cell lines.  
Densitometric analysis of PI3K phosphorylation status is expressed as phospho-PI3K/total PI3K ratio (C) and expressed 
as fold of control. Densitometric analysis of Akt phosphorylation status is expressed as phospho-Akt/total Akt ratio (D) 
and expressed as fold of control. *p < 0.05, significantly different from control cells. 
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5 Discussion 
 
The three major problems investigated and presented in this Thesis deal with the great universe of 
“ROS management”. A fine balance between reactive oxidizing species generation and antioxidant 
levels allows either the cross talk between cells or the control of fundamental intracellular 
functions. Moreover, the generation of these double-edged molecules can lead to the activation of 
survival mechanisms or trigger the cell death. This scenario is complicated by the observation that 
different cell types seem to display different redox sensitivities, different signalling pathways and 
different defence mechanisms. Beside the role of ROS in normal physiological signalling, growing 
evidence implicates alterations in redox signalling or excessive ROS production as contributors to 
many disease processes. Cancer, insulin resistance and subsequent diabetes mellitus, aging and age-
related regenerative capacity, neurodegenerative diseases and inflammation are correlated with 
intracellular redox state. In this context a critical issue is the important role played by antioxidants 
in human diet or as therapeutic agents, sometime considered “beneficial”, sometime “deleterious”. 
As stated in the “Aim of the Thesis”, the first major problem investigated concerns the role of ROS 
in biosignalling. 
After the discovery that NADPH oxidases are not only expressed in phagocytic cells, but also in a 
variety of cellular types, it has been demonstrated that these enzymes are the major source of 
intracellular ROS. NADPH oxidases are now recognized to have specific subcellular localization, 
required for localized ROS production and activation of specific redox signalling pathways (Ushio-
Fukai 2009). 
One of the surprises in redox biology was the relatively recent appreciation of hydrogen peroxide 
(H2O2) as a messenger molecule. H2O2 is considered a second messenger in different pathways, 
among them several growth factor-induced signalling cascades and insulin signalling (Sies 2014), 
which was probably the first transduction chain in which H2O2 resulted as a second messenger 
(May and de Haen 1979), inducing tyrosine phosphorylation and acting as a growth factor (Ushio-
Fukai, Tang et al. 2002). To act as a signal molecule, H2O2 has to be spatially and temporally 
produced and this is the case of H2O2 originated by the regulated NADPH oxidase enzyme, which 
produces superoxide anion outside the cell. Owing to the spontaneous dismutation or to the action 
of SOD, superoxide anions give rise to H2O2. After its production, H2O2 is not free to move across 
the membrane, in agreement with its physicochemical properties: H2O2 has, in fact, a slightly larger 
polarity than water, making its non-facilitated diffusion through the hydrophobic lipid bilayer less 
rapid than that of water (Bienert and Chaumont 2014). 
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It was experimentally demonstrated that specific AQPs facilitate H2O2 diffusion, crossing this 
uncharged molecule with the same speed of water and more rapidly than by simple diffusion 
(Bienert and Chaumont 2014). This observation has been confirmed by using specific AQPs 
inhibitor, as silver or gold nitrate, which provoked a decrease of H2O2 movement into the cell 
(Niemietz and Tyerman 2002). 
In the first set of experiments here reported, we demonstrated that, also in acute leukaemia-derived 
B1647 cell line, specific AQP isoforms constitute a possible way through which Nox-derived H2O2 
can enter the cells to act as a signal molecule. This observation has been confirmed by the inhibition 
of AQP function obtained either by AgNO3 or AQP silencing, which provoked similar results: the 
decrease of H2O2 transport when this peroxide is exogenously added or endogenously produced by 
Nox enzymes, as revealed by the evaluation of ROS intracellular levels. 
Among the many AQP isoforms, AQP1, AQP3 and AQP8 were reported to channel H2O2 through 
the plasma membrane (Bienert and Chaumont 2014). B1647 cell line expresses, at least, AQP3 and 
AQP8. Silencing or overexpression of AQP3 and AQP8 demonstrated a pivotal role played by 
AQP8 in facilitating H2O2 diffusion across plasma membrane in B1647 cells. 
The combined effect of an AQP inhibitor, AgNO3, and of a Nox-inhibitor, DPI, allows to evaluate 
the correlation between Nox-generated ROS and AQP activity. The lack of an additive effect on 
intracellular ROS level exerted by these two inhibitors suggests that they act by preventing Nox-
produced H2O2  to enter the cell in two different ways, i.e. either by blocking H2O2 production or 
transport. 
It has been previously observed that H2O2 mimics the growth factor stimulation of glucose uptake in 
leukaemia cell lines, suggesting a key role for ROS in the signalling leading to Glut1 regulation 
(Maraldi, Fiorentini et al. 2007). Furthermore, in B1647 cells, constitutively expressing both VEGF 
and its receptor VEGFR-2, VEGF is supposed to utilize ROS as messenger intermediates 
downstream of the VEGFR-2, and glucose uptake is a cellular activity strictly bound to VEGF-
induced cell proliferation. The measure of glucose transport activity obtained in AQP- and Nox-
inhibition conditions allows to demonstrate that H2O2, produced by Nox and channelled via AQP 
through the plasma membrane, is indeed able to act as a signal molecule in B1647 cells, being 
responsible for the signal leading to Glut1 activity. Moreover, data here reported demonstrated that 
when AQP8 is overexpressed in B16478 cells, the ability of VEGF to trigger an increase of H2O2 
intracellular level is enhanced; on the contrary, when AQP8 isoform was silenced, a decrease in 
intracellular ROS level triggered by VEGF was observed. These data confirm the importance of 
AQP8 basal expression in modulating VEGF-induced ROS generation.  
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There is now a consensus that VEGF family is crucial for vascular development and 
neovascularization in both physiological and pathologic processes. VEGF and VEGFR receptors, 
indeed, are not exclusively expressed by endothelial cells, but are also present in hematopoietic cell. 
This is not surprising, since during embryonic development hematopoietic and early endothelial 
cells originate from a common precursor known as hemangioblast, thus several pathways are shared 
by hematopoietic and vascular cells (Choi 1998). In recent studies, the expression of 
VEGF/VEGFR in acute myeloid leukaemia patients has been detected and the increased levels of 
plasma VEGF have been correlated with reduced survival and low remission rates (Aguayo, 
Kantarjian et al. 2002). 
The role of caveolae and lipid rafts in the regulation of signal transduction and protein trafficking is 
now well established. Rafts may contain incomplete signalling pathways that are activated when a 
receptor or other required molecules are recruited into them, or, on the contrary, they can limit 
signalling by physical sequestration of signalling components, which become in their active form 
when are released from rafts (Pike 2003; Parton and del Pozo 2013). As above mentioned, this 
concept is peculiar for redox signalling: in order to act as signal molecules, ROS must be generated 
in discrete compartments and in a controlled manner. 
Regarding this point, recent experimental evidence shows that, in endothelial cells, VEGF promotes 
the release of VEGFR-2 from caveolae/lipid rafts and its consequent activation, possibly 
stimulating NADPH oxidases (Ushio-Fukai 2007). Moreover, in endothelial cells, VEGFR-2 is 
present in caveolae through association with Caveolin-1 (Cav-1), which negatively regulates the 
receptor activity in basal state. Dissociation of VEGFR-2 from caveolae/Cav-1 seems to be essential 
for VEGFR-2 autophosphorylation and activation of downstream signalling events (Labrecque, 
Royal et al. 2003). 
To investigate the potential involvement of plasma membrane caveolae/lipid rafts in VEGF-
mediated redox signalling in B1647 cells, the experimental model employed cells cultured either in 
the presence or absence of serum. In fact, this cell type is able to auto-produce VEGF, and serum 
starved conditions allow to evaluate the cellular basal state, ruling out other growth factor effects.  
The results obtained in the second set of experiments here reported, show that when B1647 cells are 
serum starved, VEGFR-2 is present in fractions corresponding to raft and non-raft regions, whereas 
when cells are cultured in the presence of serum, VEGFR-2 content partially shifts towards non-raft 
fractions. This behaviour is consistent with higher or lower VEGF concentrations: serum starved 
cells have a lower VEGF concentration, thus VEGFR-2 is partially sequestered into caveolae/lipid 
raft regions, where it is probably linked to Cav-1; on the contrary, in serum added cells, the VEGF 
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concentration is higher, thus causing the breakage of the link Cav-1/VEGFR-2 and the consequent 
displacement of a major portion of VEGFR-2 from caveolae/lipid raft to non-raft regions.  
The methyl-β-cyclodextrin-induced disruption of caveolae/lipid rafts allows more interaction 
between VEGF and its receptor VEGFR-2, causing the shift towards non-raft regions in both 
serum-starved and serum added conditions. This facilitated formation of the VEGF/VEGFR-2 
complex causes VEGFR-2 phosphorylation and the consequent activation of downstream signalling 
pathway, leading to the increase of intracellular ROS level and glucose transport activity. 
Moreover, CD treatment increases glucose uptake through Glut1 recruitment into the plasma 
membrane from intracellular pool, in accordance with evidence reporting that Glut1 transporters are 
localized in part in caveolae/lipid rafts in many cell types (Sakyo and Kitagawa 2002) and that 
cholesterol depletion triggers its translocation from cellular stores toward the cell surface in 
leukaemia cells (Caliceti, Zambonin et al. 2012). 
In agreement with data obtained in endothelial cells (Labrecque, Royal et al. 2003), it has been 
demonstrated that, also in B1647 cells, VEGFR-2, in the absence of serum, is more linked to Cav-1; 
instead, in serum added cells, VEGFR-2 binding to Cav-1 significantly decreases promoting its 
activation, as demonstrated by the higher level of phosphorylation observed. 
It is interesting to consider the role of the protein Cav-1, which has been reported to influence both 
positively and negatively various aspects of tumour progression and to act as tumour suppressor or 
poor prognostic factor in many human cancers (Goetz, Lajoie et al. 2008). The Cav-1 scaffolding 
domain (CSD) mimics the action of Cav-1 protein, representing the portion of the protein essential 
for both Cav-1 oligomerization and the interaction with other proteins (Couet, Li et al. 1997). CSD 
binds many signalling molecules, and in many cases it negatively regulates their functions (Drab, 
Verkade et al. 2001). Results obtained in the evaluation of intracellular ROS level and glucose 
uptake activity in the presence of CSD suggest that Cav-1 may act as a negative regulator of the 
VEGFR-2 function also in B1647 cells. 
The results obtained with Bevacizumab (Ferrara, Hillan et al. 2004) and Semaxinib (Fong, Shawver 
et al. 1999), able to inhibit the VEGF/VEGFR-2 interaction with different mechanism of action, 
confirm the importance of this molecular complex in maintaining the redox loop leading to high 
intracellular ROS level and glucose uptake activity in B1647 cells. The importance of inhibit 
tumour angiogenesis is now recognized as an helpful tool in therapeutic strategy, nevertheless, the 
wide adverse effects induced by anti-VEGF agents demonstrated that these drugs have a broad 
impact on vasculatures in multiple healthy tissues and organs (Folkman 1971). 
The second major problem investigated concerns the role of natural or physiological molecules in 
maintaining or altering the ROS balance inside the cells. 
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The issue of protective versus deleterious roles for both endogenous and diet-derived antioxidants 
in health and diseases is highly debated. From the many reviews published on this topic, G.E. Mann 
and co-workers observed that, although epidemiological evidence suggests that diets containing 
high amounts of natural antioxidants afford protection against coronary heart disease, antioxidant 
supplementation trials have largely reported only marginal health benefits (Mann, Rowlands et al. 
2007). A convincing point of view comes from B. Halliwell, who claims that, provided one is not 
deficient in vitamins, the antioxidant defences that we synthesize ourselves are far more important 
than any antioxidant benefit deriving from large supplementation of vitamins E, C, carotenoids or 
flavonoids. Thus, agents that stimulate our adaptation systems and elevate our endogenous 
antioxidant defences and other protective systems may be more protective against tissue damages 
due to oxidative stress than the consumption of large amounts of vitamins or antioxidants (Halliwell 
2012). 
One of the most important of the adaptation system is the nuclear factor erythroid 2-related factor 2, 
Nrf2, a transcription factor that increases levels of several protective agents, such as reduced 
glutathione, and the expression of endogenous antioxidants, such as heme oxygenase 1 (HO-1) or 
peroxiredoxin-1, (Prx-1), in response to toxic agents (Kasper et al, 2009).  
Many nutraceuticals compounds, extracted from a variety of plants, are able to activate Nrf2 
pathways, such as resveratrol, pterostilbene, sulforaphane, curcumin, cafestol, quercetin, and 
epigallocatechin-3-gallate (Balstad, Carlsen et al. 2011). To this regard, it has been shown that 
vascular cells respond to an environmental oxidative stress by inducing endogenous antioxidant 
defence mechanisms and that dietary antioxidants may counteract oxidative stress in vascular and 
inflammatory diseases by modulating key redox sensitive gene transcription via NF-κB and 
Nrf2/ARE signalling pathways (Mann, Rowlands et al. 2007). Among the endogenous antioxidant 
defences, the recent discovery of the Klotho protein raised a great appeal, since the Klotho gene was 
identified as an “aging suppressor” in mice (Kuro-o 2011).  
In the experiments performed at the King's College London, human aortic smooth muscle cells 
(HASMC) were subjected to three different conditions, in order to mimic an hyperglycaemic status, 
and treated with sulforaphane or exogenous Klotho. Results show that both these treatments 
induced significant increases in HO-1 and Prx-1 expression, confirming that sulforaphane is able to 
stimulate Nrf2/ARE signaling pathways and that the Klotho protein takes part on the natural 
antioxidant defenses. Moreover, both sulforaphane and Klotho treatments were able to strongly 
elevate GSH intracellular levels and to completely restore the significant depletion of GSH levels 
observed after 48 hours HASMC exposition to HG condition. These data contribute to partially 
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clarify the antioxidant effect of Klotho, which could proceed through the modulation of GSH 
intracellular levels. 
Nevertheless, the similar results observed in the three experimental conditions tested, suggest that 
these conditions are not stressing enough to appreciate significant differences between a normal 
glucose concentration and a simulated pathological status. Alternative experimental strategies 
should be adopted to carry on this study in the future. 
The third faced problem, i.e. the study of the antioxidant and antihyperglycemic properties of 
natural molecules (Stevia extracts) used for their anti-diabetes effect, deals once again with the ROS 
balance inside the cells, providing a more applied approach. 
At present, researchers worldwide agree on the antidiabetic Stevia effect, but they differ on how this 
effect proceeds through. Some assert that Stevia’s utility is due to the antioxidant properties of its 
leaves, which have been reported both in vitro and in vivo (Shivanna, Naika et al. 2013; Tavarini 
and Angelini 2013). Some other state that steviosides are able to down-regulate the NF-kB pathway 
and TNFα expression, modulate insulin secretion and sensitivity and inhibit hepatic 
gluconeogenesis (Mohd-Radzman, Ismail et al.). Therefore, many points concerning the mechanism 
of action of these compounds need to be clarified.  
In order to study the potential insulin-like properties of the most used Stevia extracts, the human 
neuronal cell line SH-SY5Y is of particular interest, since it has been recently reported that in these 
cells Glut1 translocation in response to insulin-like growth factor occurs and, for the first time in a 
neuronal cell system, also Glut4 translocated to the plasma membrane in response to insulin 
(Choeiri, Staines et al. 2002). The evaluation of the intracellular ROS level demonstrated that the 
Stevia extracts tested failed to exert any antioxidant effect in both SH-SY5Y and HL-60 cells, in 
contrast with data reported in the literature. On this regard, it has to be pointed out that Stevia leaves 
were properly reported to have antioxidant activity, probably due to their naturally elevated amount 
of polyphenols (Shivanna, Naika et al. 2013), whereas the compounds used in the present study are 
commercial sweeteners, containing 95-98% steviol glycosides with non appraisable amount of 
polyphenols. 
Interesting results were obtained in the evaluation of the glucose transport activity, since the 
different Stevia extracts tested were as efficient as insulin in increasing the glucose uptake of both 
cell lines. Moreover, the co-treatment with insulin and Stevia extracts causes a rise in glucose 
transport significantly higher than the increase due to insulin alone, revealing an additive effect 
between these two stimuli. The expression of glucose transporter isoforms observed in 
neuroblastoma and leukaemia cells following treatment with insulin or Stevia extracts demonstrated 
that both these stimuli provoke a Glut1 and Glut4 recruitment from intracellular pools to the plasma 
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membrane of HL-60 and SH-SY5Y cells, thereby inducing the increase in the glucose transport 
activity. These data provide important evidence supporting the insulin-like effect of steviol 
glycosides in human cells and clarify one of their possible mechanism of action. On this regard, the 
investigation of the signal transduction pathway involved in the effect of these two stimuli 
demonstrated that the phosphorylated forms of both PI3K and Akt were significantly increased 
upon the treatment with insulin or Stevia extracts, indicating a possible similar mechanism of action 
or, at least, a common signalling pathway shared by these two stimuli, which can explain their 
observed additive effect.  
In conclusion, these data suggest that steviol glycosides act by modulating Gluts translocation 
through PI3K/Akt pathway, giving evidence about their recommended use as natural sweeteners for 
diabetic patients. 
 
Fig. 36. H2O2 signalling in B1647 human acute myeloid leukaemia cell line.  
The major source of intracellular ROS is the NAD(P)H oxidase family (Nox), which play an important role 
in biological processes, producing extracellular superoxide (O2¯). Two molecules of O2¯ can dismutate and 
produce hydrogen peroxide (H2O2) in the presence of the enzyme superoxide dismutase (SOD) (Lambeth 
2004). AQPs is a channel through which H2O2 or H2O can enter into the cell; in particular AQP1 isoforms 
facilitate the passive diffusion of H2O across biological membranes, whereas AQP3 and AQP8 are more 
specific for H2O2 diffusion. AgNO3 inhibits AQPs, while DPI blocks Nox. Caveolae/lipid rafts are membrane 
regions rich of cholesterol and sphingolipids and act as platforms for compartmentalization of proteins 
involved in signal pathway (Patel and Insel 2009). Vascular endothelial growth factor receptor (VEGFR) 
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colocalizes with Caveolin-1 (Cav-1) into caveolae, and also insulin growth factor receptor (IGFR) and the 
glucose transporter 1 (Glut1) are partially localized in these domains.  
In B1647 cells, constitutively expressing both VEGF and its receptor VEGFR-2, VEGF is supposed to utilize 
ROS as messenger intermediates downstream of the VEGFR-2. Upon the formation of VEGF/VEGFR-2 
complex, Nox is activated and H2O2 produced extracellularly is channelled via AQP3/AQP8 through the 
plasma membrane. Inside the cell, H2O2, is able to act as a signal molecule, being responsible for the signal 
leading to Glut1 activity. 
Bevacizumab inhibits VEGF; Semaxinib inhibits VEGFR-2, Caveolin scaffolding domain peptide (CSD) 
mimics Cav-1, acting as a negative regulator of the VEGFR-2 function. All these compounds confirm the 
importance of VEGF/VEGFR-2 complex in maintaining the redox loop leading to high intracellular ROS 
level and glucose uptake activity in B1647 cells. 
 
Fig. 37. Proposed mechanism of effects provided by SF and Klotho in HASMC.  
The representative figure of sulforaphane (SF) and Klotho mechanisms is an adaptation of (Tarozzi, Morroni 
et al. 2009). Human aortic smooth muscle cells (HASMC) were subjected to different conditions, in order to 
mimic an hyperglycaemic status, and treated with SF or exogenous soluble Klotho. High glucose and AGEs 
increase ROS production (Chen and Kong 2004). 
SF is an isothiocyanate present in cruciferous vegetables that induces antioxidant defence enzymes through 
Keap1/Nrf2 transcriptional activation (Angeloni, Leoncini et al. 2009; Alfieri, Srivastava et al. 2011). Under 
basal conditions, Keap1, that contains cysteine residues, binds Nrf2. When SF, or other compounds or 
oxidative stress change the eletrofilic balance, the cysteine residues are oxidized and Nrf2 is released (Baird 
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and Dinkova-Kostova 2011). Nrf2 translocates to the nucleus where binds ARE (Antioxidant Responsive 
Element) in the presence of Maf proteins (Baird and Dinkova-Kostova 2011). ARE increase the synthesis of 
many ARE-dependent antioxidant enzymes in different cell systems (Angeloni, Leoncini et al. 2009), such as 
glutathione reductase (GR), glutathione peroxidase (GPx), heme oxygenase (HO-1), NAD(P)H-
Quinone:Oxidoreductase (NQO1), peroxiredoxin-1 (Prx-1), and glutaredoxin, thioredoxin, thioredoxin 
reductase. It has been shown that SF directly interacts with Keap1 by covalent binding to its thiol groups 
(Dinkova-Kostova, Holtzclaw et al. 2002). 
Klotho, a protein with multiple pleiotropic effects, exists in membrane and secreted forms with distinct 
functions. The trans-membrane protein form is a co-receptor for FGF23, although the mechanisms involved 
in its action remain to be fully elucidated. 
Klotho increases HO-1 and Prx-1 expression. Both SF and Klotho treatments were able to elevate GSH 
intracellular levels and to completely restore the significant depletion of GSH cell contents observed after 
48-h exposition to high glucose conditions. 
 
 
 
Fig. 38. Proposed mechanism of Steviol Glycosides effects on SH-SY5Y and HL60. 
Steviol glycosides, primarily stevioside and rebaudioside A, are natural constituents of the plant Stevia 
rebaudiana Bertoni. Insulin increases glucose uptake in cells by stimulating the translocation of the glucose 
transporters (Glut1 and Glut4) from intracellular stores to the cell surface. 
The PI3K/AKT pathway is a key component of the insulin signalling cascade and is essential for glucose 
transport, inducing the translocation of Glut4. Rebaudioside A and three different mixtures of steviol 
glycosides activate the same PI3K/Akt pathways, showing an insulin-like effect. 
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6 Conclusions 
 
Results reported in this Thesis contribute to the comprehension of the complicated world of “redox 
biology”. 
Having a clear understanding of how ROS regulate signalling pathways both in physiological 
responses and in pathogenesis and progression of diseases will allow to develop strategies in order 
to improve well-being or to uncover new therapeutic targets.  
In cancer cells, the increase in ROS generation from metabolic abnormalities and oncogenic 
signalling may trigger a redox adaptation response, leading to an up-regulation of antioxidant 
capacity in order to maintain the ROS level below the toxic threshold. Thus, cancer cells would be 
more dependent on the antioxidant system and more vulnerable to further oxidative stress induced 
by exogenous ROS-generating agents or compounds that inhibit the antioxidant system. The 
modulation of ROS content above or below the threshold level could lead to cell death, and this 
might constitute a biochemical basis to design therapeutic strategies to selectively kill cancer cells. 
Results here reported indicate that the development of new drugs targeting specific Nox isoforms, 
responsible for intracellular ROS generation, or AQP isoforms, involved in the transport of 
extracellular H2O2 toward intracellular targets, might be an interesting novel anti-leukaemia 
strategy.  
Furthermore, also the use of CSD peptide, which simulate the VEGFR-2 segregation into caveolae 
in the inactive form, might be a strategy to stop the cellular response to VEGF signalling.  
As above stated, in the understanding of the redox biology, it is also important to identify and 
distinguish the molecular effectors that maintain normal biological and physiological responses, 
such as agents that stimulate our adaptation systems and elevate our endogenous antioxidant 
defences or other protective systems. Data here reported indicate that the nutraceutical compound 
sulforaphane and the Klotho protein are able to stimulate the HO-1 and Prx-1 expression, as well as 
the GSH levels, confirming their antioxidant and protective role.  
Finally, results here reported demonstrated that Stevia extracts are involved in insulin regulated 
glucose metabolism, suggesting that the use of these compounds goes beyond their sweetening 
power and may also offer therapeutic benefits hence improving the quality of life. 
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List of abbreviations 
 
OH Hydroxyl Radical 
Ac-DEVD-AMC acetyl-Asp-Glu-Val-Asp-aminomethylcoumarin 
AGE Advanced glycation end products 
AML Acute myeloid leukemia 
AngII Angiotensin II 
ANOVA Analysis of variance 
AQP Aquaporin 
ARE Antioxidant response element 
BSA Bovine serum albumin 
B1647 Human erythromegakaryocytic leukemia cell line 
bZip Basic leucine zipper 
Cav-1 Caveolin-1 
CD Methyl-β-cyclodextrin 
CD71 Transferrin receptor 
CSD Cav-1 Scaffolding Domain 
CVD Cardiovascular diseases 
Cyp Cytochrome 
DAG Diacylglycerol 
DCF 2',7'-dichlorofluorescein 
DCFH-DA Dichlorofluorescin diacetate  
DMSO Dimethyl sulfoxide 
DMEM Dulbecco’s modified Eagle’s medium 
DNA Deoxyribonucleic acid 
DOG 2-deoxy-D-glucose 
DPI Diphenyleneiodonium chloride 
EDTA Ethylenediaminetetraacetic acid 
ELISA Enzyme-linked immunosorbent assay 
eNOS Endothelial nitric oxide synthase 
ERK Extracellular signal-regulated kinases 
FADH Flavin adenine dinucleotide 
FBS Foetal bovine serum 
FGF Fibroblast growth factor 
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FOXO Forkhead box O 
GF growth factor  
GLUT Glucose transporter 
GPx Glutathione peroxidase 
GRed Glutathione reductase 
GSH Glutathione 
GSK3 Glycogen synthase kinase 3 
GSSG Oxidised glutathione 
GST Glutathione S-transferase 
H2DCFDA 2',7'-dichlorodihydrofluorescein diacetate 
H2O2 Hydrogen peroxide 
HAD highly efficient and unaltered antioxidant defences 
HBSS Hanks’ Balanced Salt Solution 
HG High Glucose  
HIF-1 Hypoxia inducible factor-1 
HO-1 Heme oxygenase-1 
HRP Horseradish peroxidase 
HS Human serum 
HUVEC Human umbilical vein endothelial cell 
I Insulin 
IGF Insulin-like growth factor 
IL Interleukin 
iNOS Inducible nitric oxide synthase 
IR Insulin receptor 
IRE1 Inositol-requiring kinase 1 
IRS Insulin receptor substrate 
LAD low antioxidant defences 
LDH Lactate dehydrogenase 
JNK c-jun N-terminal kinase 
Keap1 Kelch-like ECH-associating protein 1 
Kl Klotho 
MAPK Mitogen-activated protein kinase 
MnSOD Manganese superoxide dismutase 
mRNA Messenger ribonucleic acid 
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MTT (3-(4,5 – dimethylthiazol – 2 – yl) – 2,5 – diphenyltetrazolium bromide 
Man Mannitol 
NAD Nicotinamide-adenine dinucleotide 
NADH Reduced nicotinamide-adenine dinucleotide 
NADP+ Oxidised nicotinamide-adenine dinucleotide phosphate 
NADPH Nicotinamide adenine dinucleotide phosphate 
NG Normal Glucose 
NO+ Nitrosonium Cation 
NO¯  Nitroxyl Anion 
NF-κB Nuclear factor kappa B 
NO Nitric oxide 
NOS Nitric oxide synthase 
Nox NAD(P)H oxidase 
NQO1 NAD(P)H quinone oxidoreductase 1 
Nrf2 Nuclear factor erythroid 2-related factor 2 
O2 ̇- Superoxide 
ONOO¯  Peroxynitrite 
OPA O-phthaldialdehyde 
oxLDL Oxidised low-density lipoproteins 
PBS Phosphate-buffered saline 
PH pleckstrin homology 
PI3K Phosphatidylinositol 3-kinase 
PIP3 Phosphatidylinositol-(3, 4, 5)-trisphosphate 
PKB (or Akt) Protein Kinases Protein Kinase B  
Prx Peroxiredoxin 
PTP Protein Phosphatases 
PVDF Polyvinylidene difluoride 
RNS Reactive nitrogen species 
ROS Reactive Oxidizing Species 
SD Standard Deviation  
SEM Standard Error Mean  
SDS-PAGE Sodium dodecyl sulfate- poly acrylamide gel electrophoresis 
SF Sulforaphane 
siRNA Small interfering ribonucleic acid 
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SMC Smooth muscle cell 
SOD Superoxide dismutase 
STZ Streptozotocin 
TCA Trichloroacetic acid 
TCA cycle Tricarboxylic acid cycle 
TEMED Tetramethylethylenediamine 
TGF-β Transforming growth factor beta 
TNF-α Tumour necrosis factor α 
Trx Thioredoxin 
TrxR Thioredoxin reductase 
VCAM-1 Vascular cell adhesion molecule-1 
VSMC Vascular smooth muscle cell 
VEGF Vascular endothelial growth factor 
VEGFR-1 Vascular endothelial growth factor receptor 
WHO World Health Organisation 
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